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Yaling Huang, M.D. 
Supervisory Professor: Lei Li, Ph.D. 
 
Cells derived from Fanconi anemia (FA) patients are characterized by 
hypersensitivity to DNA interstrand crosslinks (ICLs), suggesting that FA genes play a role 
in ICL repair. Fanconi anemia core complex (including A, B, C, E, F, G, L, FAAP20, and 
FAAP100) activates the Fanconi pathway by providing the essential E3 ligase activity for 
FANCD2 mono-ubiquitination. Previous studies suggested the existence of three protein-
protein interaction groups. However, the functions of most FA core complex protein are still 
limited to their presence in the complex. How the spatially-defined FANCD2 ubiquitination 
is accomplished by the core complex remains unknown.  
To elucidate the roles of FA core complex proteins in ICL response, especially their 
contribution to FANCD2 ubiquitination, we established isogenic knockout mutants deficient 
in FA core genes and determined the loss-of-function effects on the activation of FA pathway 
and on cellular survival against ICLs. Our results suggest three potential functional modules 
in the FA core complex: FANCB-FANCL-FAAP100 (B-L-100), FANCA-FANCG-FAAP20 
(A-G-20), and FANC-FANCE-FANCF (C-E-F). We showed that the B-L-100 sub complex 
is the catalytic module absolutely required for the E3 ligase function of FA core complex.  
The A-G-20 module anchors the catalytic module to the chromatin. The C-E-F module acts 
as a loading factor of the core complex through FANCM. Our work revealed that the FA core 
complex is assembled with functional modules and carries out the spatially-defined FANCD2 
monoubiquitination reaction to ensure that nucleases for DNA damage processing are 
vi 
enriched at the site of lesion. The deviate functions of different FA core complementation 
groups imply differential disease biology related to prognosis and treatment. 
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CHAPTER I 
Background and Significance 
 
Fanconi anemia 
Fanconi anemia (FA) is named after the Swiss pediatrician Guido Fanconi, who first 
described this human disease in 1927 (Lobitz and Velleuer, 2006). FA is a rare genetic 
disease typically characterized with bone marrow failure, a broad spectrum of developmental 
abnormalities, and a propensity to cancer. FA occurs in all ethnic groups with an average 
incidence of 1/130,000 births in US, although it is more prevalent in Israel with a birth 
incidence of 1/35,000 (Rosenberg et al., 2011). The heterozygous carrier frequency is 1/181 
in US, while the carrier frequency is up to 1/93 in Israel and 1/100 in Ashkenazi Jews, 
Afrikaners, Spanish Gypsies, black sub-Saharan Africans (Rosenberg et al., 2011). The 
median age at death of FA patients was 30 as recorded in 2000 (D'Andrea). 
The major symptoms of FA are pancytopenia, diverse congenital abnormalities, and a 
marked susceptibility to develop cancer. It is most commonly characterized in clinical 
practice by pancytopenia, leading to hypoxia in organs, higher risk of infection, and 
continuous bleeding, as result of patient bone marrow failure. Thus bone marrow and 
umbilical cord blood transplantation are relatively effective treatment for FA patients. 
 Congenital defects occur in about 67% FA patients, including but not limited to 
skeletal malformations (manifested by short stature, microcephaly, dangling thumbs, and 
rocker bottom feet, etc.), urogenital abnormalities, and skin pigmentation, etc. (Auerbach et 
al., 1989). FA patients have high risk of cancer development, 48-fold and 800-fold higher 
risk of developing solid tumor and acute myeloid leukemia, respectively (Rosenberg et al., 
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2003). They are also prone to many other cancer types such as leukemia, head-and-neck 
squamous cell carcinoma, esophageal carcinoma, gynecological carcinoma, and tumors in 
liver, brain, skin, and kidney. Among them acute myeloid leukemia has the highest frequency 
(Kutler et al., 2003). Certain genetically defined groups of FA patients are more prone to 
breast cancer and ovarian cancer (Akbari et al., 2010; Howlett et al., 2002). 
FA is a DNA repair-deficiency disorder which is closely associated with 
chromosomal instability and hypersensitivity to DNA damage reagents. Other examples of 
DNA repair-deficiency disorders include Nijmengen syndrome, Bloom syndrome, and 
Xeroderma pigmentosum. One of the key features of FA is that cells derived from patients 
are hypersensitive to DNA crosslinking agents, such as mitomycin C (MMC), cisplatin, 
formaldehyde, etc.  This specific feature is used to clinically diagnose the FA disease. And 
DNA interstrand crosslinking repair in FA cells has been investigated to understand the 
biological mechanism of this disease. 
 
Fanconi anemia gene 
FA is a highly complex genetic disorder, consisting of at least 16 complementation 
groups (A, B, C, D1, D2, E, F, G, I, J, L, M, N, O, P, Q). Each FA complementation group is 
caused by mutation(s) of a distinct disease gene encoding a corresponding FA protein. 
Previously, complementation assay based on cell fusion techniques were used to distinguish 
different FA genes. With the emergence of functional cloning and sequencing technique, 
several new FA genes were discovered (Bogliolo et al., 2013). Among the 16 FA genes, most 
were autosomal recessive, except for FANCB, which is X-linked. The summary of the 
prevalence, chromosomal location, and conservation is listed in Table 1.1. 
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Another group of genes are found to be physically and/or functionally associated with 
FA genes. Therefore, most of their protein products were named as FA-associated proteins, 
including FAAP24, FAAP20, FAAP100, FAAP16 (also named MHF1), and FAAP10 
(MHF2), and, FAN1 (FANCD2-associated nuclease). Until now, no mutation has been found 
in these FA-associated genes even though they contribute to DNA interstrand crosslink 
repair. The summary of these genes is listed as Table 1.2. 
 
 
 
 
 
3 
 
Table 1.1 Fanconi anemia genes. 
 
Adapted (with permission) from NATURE PUBLISHING GROUP on behalf of Nature Reviews Genetics, (Wang, 2007), copyright (2007).  
Prevalence in FA patients are calculated as total number of individuals with variants of the specific FA gene/ total genetically identified FA patients 
63% + Phosphorylated 
following DNA
damage
FANCB Xp22.2 ~2% vertebrate + Core complex Contains nuclear 
localization sequence
FANCC 9q22.3 12% vertebrate + Core complex
FANCD1           
( BRCA2) 13q12.3 ~2%
vertebrate, 
worm -
Homologous 
recombination
Contains BRC repeats 
and an OB‑fold DNA 
binding domain; 
regulates RAD51
~3% +
Monoubiquitylated 
and phosphorylated 
following DNA
damage; exonuclease 
activity
FANCE 6p22-p21 ~2% vertebrate + Core complex
Phosphorylated by 
Chk1 following DNA 
damage
FANCF 11p15 ~2% vertebrate + Core complex
FANCG            
( XRCC9) 9p13 9% vertebrate + Core complex
Contains TPR repeats; 
phosphorylated 
following DNA 
damage
~1% +
Monoubiquitylated 
and phosphorylated 
following DNA
damage
FANCJ   
(BRIP1, 
BACH1)
17q22.2 ~2%
vertebrate, 
invertebrate, 
yeast
-
Homologous 
recombination
5’ to 3’ DNA 
helicase; binds 
BRCA1; 
phosphorylated 
following DNA 
damage; G-
quadruplex resolution
+ PHD/ring-finger 
ubiquitin-ligase
activity; contains 
WD40 repeats
FANCM     
(Hef)
14q21.2 ~0.2%
vertebrate, 
invertebrate, 
yeast, archaea
+ Core complex
Contains helicase and 
endonuclease 
domains;  
phosphorylated 
following DNA 
damage
FANCN 
(PALB2)
16p12.2 ~0.6% vertebrate - Homologous 
recombination
An essential partner 
for BRCA2 stability 
and nuclear 
localization 
FANCO 
(RAD51C) 17q22 ~0.4%
vertebrate, 
invertebrate, 
yeast
-
Homologous 
recombination
RAD51 paralogue, 
single-stranded DNA-
dependent ATPase 
activity
FANCP   
(SLX4) 16p13.3 ~0.5%
vertebrate, 
worm, insect, 
yeast, bacteria
-
Nucleolytic cleavage / 
Homologous 
recombination
Scaffold protein in 
structure-specific  
endonuclease 
complex; Holliday 
junction resolvase 
FANCQ    
(XPF, ERCC4) 16p13.12 ~0.1%
vertebrate, 
insect, plant 
yeast, bacteria, 
archaea
- Nucleolytic cleavage
contains the nuclease 
domain, HhH2 
domain, and helicase-
like domain
FA gene Chromosome 
location
Function in FA pathway Protein features
FANCA 16q24.3 vertebrate Core complex
FANCL       
(PHF9) 2p16.1
vertebrate,  
insect, slime 
mould
Core complex
Prevalence in FA 
patients
conservation
important for 
FANCD2 
ubiquitnation
~0.1%
FANCD2 3p26
vertebrate, 
worm, insect, 
slime mould
ID complex
FANCI 15q26.1
vertebrate, 
worm, insect, 
slime mould
ID complex
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Table 1.2 Fanconi anemia-associated genes. 
 
 
 
Fanconi anemia pathway in DNA interstrand crosslink repair 
A DNA interstrand crosslink (ICL) is formed when DNA crosslinking agent 
covalently links two nucleotide residues from the opposite strands. ICLs block essential 
cellular DNA metabolism especially DNA replication and transcription by preventing DNA 
strand separation. It is extremely toxic to cells if left unrepaired, the fatal dosage is one for 
unicellular organism, and 20-40 for mammalian cells (Lawley and Phillips, 1996; Magana-
Schwencke et al., 1982). The genotoxicity and mutations from ICLs lead to genomic 
instability and cancer development. The cancer risk manifestation of FA and the ICL repair 
deficient disease fully demonstrated this notion. On the other hand, the strong cytotoxicity of 
ICLs in dividing cells prompt the clinical application of ICL agents in cancer therapy, both in 
solid and blood-borne tumors since 1940.   
The crosslinking agents exist both intrinsically and extrinsically. The natural 
crosslinking agents include mitomycin C, psoralens, nitrous acids, etc. Mitomycin C (MMC), 
5 
 
also named [6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-
octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate, is originated from 
fungi. MMC functions as an antibiotic by causing DNA crosslinking to kill bacteria. As an 
anti-cancer agent, MMC has been administrated to treat breast, esophageal, and bladder 
cancer. There are also synthetic sources of crosslinking agents such as cisplatin, nitrogen 
mustard, etc. Cisplatin, also named (SP-4-2)-diamminedichloridoplatinum, is the first 
member of the platinum-containing anti-cancer agents. Until now it is still one of the most 
widely-used chemotherapeutical agents for cancer treatment. Another DNA crosslinking 
agents used in my study is formaldehyde. Aldehyde is a metabolite of alcohol consuming and 
a major byproduct of cellular demethylation process. Recent studies have shown that 
formaldehyde is an internal risk for genomic instability and embryogenesis (Rosado et al.).  
Understanding of cellular mechanism in response to ICLs is important not only 
because failure in proper ICL repair results in genomic instability and cancer development, 
but also because ICL-inducing agent with its profound cytotoxicity is a widely-used 
chemotherapeutic drug for cancer treatment. To date, two repair mechanisms have shown to 
be involved in ICL repair in eukaryotes, a recombination-dependent and arecombination-
independent pathway. The recombination-dependent ICL repair, also called the replication-
dependent ICL repair, mainly occurs in S or G2 phases of cell cycle when the undamaged 
sister chromatid is present. The recombination-independent ICL repair, also known as the 
replication-independent ICL repair, mainly occurs in G1 phase of the cell cycle and is usually 
mutagenic.  
Recombination-dependent ICL repair is initiated by the stalling of the replication 
fork, and processed by nucleotide excision repair (NER), translesion synthesis, and 
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homologous recombination (HR). Current model is derived from studies in the Xenopus 
laevis egg extracts (Raschle et al., 2008) as shown in Fig. 1.1A. In this model, either dual 
replication forks converge at the DNA ICL site (20%) or single replication fork get stalled at 
the ICL site and FANCM-MHF1/MHF2 complex mediates the replication traverse (>50%) 
(Huang et al., 2013). Then structure-specific nucleases such as XPF-ERCC1 make dual 
incisions flanking the lesion site on one DNA strand, which is also called an ICL unhooking 
step. Next, a translesion DNA polymerase fills the resulting gap. This strand is later ligated to 
the downstream Okazaki fragment, which is synthesized before the replication fork stalling. 
This restored DNA duplex is then further repaired by NER factors by removing the 
crosslinked oligonucleotides. This fully repaired duplex subsequently serves as template to 
rejoin the double strand break on the other duplex by homologous recombination. 
In the recombination-dependent ICL repair mechanism, the FA pathway is 
indispensable from the initial recognition of stalled replication forks to the final 
recombination process (Wang and Gautier, 2010). As shown in Fig. 1.2, the FA classical core 
complex (consisting of A, G, FAAP20, C, E, F, B, L, and FAAP100) is recruited to the ICL 
sites by FANCM and its associated proteins (FAAP24, MHF1/2). The core complex activates 
the FANCI/D2 complex by ubiquitination. The monoubiquitinated FANCI/D2 then recruits 
crucial ICL repair factors, including excision factors such as SLX4 and FAN1, through their 
ubiquitin-binding domains (Liu et al.; Yamamoto et al., 2011). Also, the homologous 
recombination factors of FA pathway is central for the ensuing homologous recombination in 
order to complete the repair of the DSB-bearing sister chromatid (Garcia-Higuera et al., 
2001).  
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Recombination-independent repair or mutagenic ICL repair is initiated when ICL is 
recognized by native DNA damage recognition factors such as XPC and consists of NER 
incision and translesion synthesis (Sarkar et al., 2006; Zheng et al., 2003), as shown in Fig. 
1.1B. NER incision factors are utilized to unhook the covalently-joined strand, in which 
XPF-ERCC1 and XPG provide the 5’ and 3’ incision, respectively. The resulting gap of 
unhooking is then filled by lesion bypass DNA polymerase ζ (Shen et al., 2006). A second 
incision then occurs on the other strand to accomplish the repair of the DNA ICL. The FA 
core and FANCI/D2 complexes are also involved in this process (Shen et al., 2009), but 
downstream FA proteins, such as FANCJ, are not. Also a recent study demonstrated that 
FAAP20 protein may recruit the FA core complex to the ICL site in the replication-
independent pathway (Yan et al.). 
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Fig. 1.1 Interstrand crosslink repair pathways in vertebrates.  
(A) Recombination-dependent ICL repair pathway includes initiation, unhooking, (SNMA1 
digestion), translesion synthesis, nucleotide excision, gap filling, and homologous 
recombination.  
Note, it is adapted from Raschle, M., et al. in 2008 (Raschle et al., 2008). However, in their 
study, as shown in green-arrowed strands, SNM1A digestion step is not necessary. Instead, 
the new strand is extended to one base beyond the lesion, nucleases exerts unhooking, Rev1 
inserts a cytosine across the lesion, and Pol ζ processes the lesion bypass synthesis. 
(B) Recombination-independent ICL repair pathway includes initiation, unhooking, 
translesion bypass synthesis, nucleotide excision, and gap filling.  
Note, it is adapted from Zheng H. et al. in 2003 (Zheng et al., 2003). 
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Adapted (with permission) from Pioneer Bioscience Publishing Company on behalf of Translational Cancer Research,  (Huang and Li, 2013), copyright (2013) 
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 Fig. 1.2  Fanconi anemia pathway.  
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Fanconi anemia core complex and its E3 ligase activity 
As mentioned above, the classical Fanconi anemia core complex consists of A, G, C, 
E, F, B, L, and two FA associated protein FAAP100 and FAAP20. So far, the functional 
understanding of the core complex is limited to the E3 ligase activity for FANCI/D2 
ubiquitination which is central for FA pathway activation. The general paradigm is that all 
the core components work together as an integral complex to exert the E3 ligase function; 
deficiency of either component will collapse the whole complex, leading to the loss of 
FANCD2 ubiquitination. Aside from FANCL that possesses the RING domain and bears the 
E3 ligase activity (Alpi et al., 2008; Meetei et al., 2003), most other components do not have 
recognizable domains or clearly-designated functions as to how they contribute to the 
FANCD2/I ubiquitination upon ICL agent-induced DNA damage. 
In order to study the E3 ligase activity of the core complex, we have compared the 
composition of the core complex with other types of E3 ligases. There are two general 
categories of E3 ligases as shown in Fig. 1.3. One is the Cullin-based multi-components E3 
with adaptor and substrate-binding modules. The other is the monomeric E3s including the 
HECT domain and U-box domain proteins (Metzger et al., 2012; Zimmerman et al., 2010). 
By sheer number of components, the FA core complex fits in the former category, but it is 
conflicted by the experimental observation that FANCL itself was sufficient to ubiquitinate 
the FANCD2 (Alpi et al., 2008; Longerich et al., 2009). Also there is a unique aspect for the 
FA core complex, which is apparently recruited to and anchored at the site of DNA damage 
to prevent the detrimental impact of enriching lesion-processing nucleases to undamaged 
DNA. Therefore we hypothesize that certain core complex components must function to 
support the spatially defined FANCD2 monoubiquitination reactions upon DNA damage.   
13 
 
  
Fig. 1.3 FA core complex E3 ligase compared with two classes of E3 ligases – one of a kind 
or fitting in? 
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Fanconi anemia sub complex 
Previous protein-protein interaction studies suggested that FA core proteins form sub 
complexes. These sub complexes may be important in loading the core complex to the 
damaged sites and in response to other kinds of DNA damage such as oxidative stress (Futaki 
et al., 2002). Before our study, these sub complexes and their specialized functions in ICL-
induced DNA damage response are not clear.  
As to the sub complex involving FANCG, previous studies have shown that FANCG 
interacts with FANCA and FAAP20, forming an FANCA-FANCG sub complex (Ali et al.; 
Yan et al.). FAAP20 is suggested to anchor FANCL to the damaged site through binding to 
ubiquitinated histone (Yan et al.).  FANCA has been shown to bind to DNA which likely 
contributes to the recruitment of the core components to the DNA damage site for ICL repair 
(Yuan et al., 2012). Additionally, FANCG plays a structural role as a scaffolding protein with 
the TPR motifs (Blom et al., 2004; Hussain et al., 2006).  
FANCB, FANCL, and FAAP100 form the B-L-100 sub complex as (Ling et al., 
2007; Medhurst et al., 2006). Interestingly, in vitro studies have indicated that FANCL itself 
was sufficient to ubiquitinate the FANCD2, in the absence of the whole core complex 
(Longerich et al., 2009; Sato et al., 2012). Thus, it suggests that the function of other core 
components might be either optimizing the E3 ligation action to enhance the efficiency, or 
facilitating its localization to the damage sites.  
FANCC, FANCE, and FANCF form the third sub complex inside the FA core 
complex. Similar to the A-G-20 and B-L-100 sub complexes, FANCC, FANCE, and FANCF 
also interact and stabilize each other. Previous studies have shown that FANCF acts as an 
adapter protein for the core complex (Leveille et al., 2004). Recent studies also showed that 
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FANCF binds to FANCM through the N-terminal 158aa motif of FANCF and the MM2 
motif of FANCM. This interaction might contribute to the loading of the core complex to the 
DNA damage sites (Deans and West, 2009). 
Taken together, there are three sub complexes existing in the core complex, which 
may exert unique functions contributing to the FANCI/D2 ubiquitination and ICL repair. 
Based on the presence of the sub complexes, we performed epistatic analysis among the core 
component genes and hypothesized that there are different functional modules in the core 
complex enabling the spatially defined monoubiquitination reaction of FANCI/D2 complex. 
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 CHAPTER II 
Generation of FA Core Gene Somatic Knockout Cell Lines 
 
Introduction 
Based on the current model, FA core complex consisting of six FA proteins (A, B, C, 
E, F, G, and L) and two FA associate proteins (FAAP20 and FAAP100), activates the FA 
pathway upon DNA damage by ubiquitinating the FANCI/D2 complex. This ubiquitination 
event is a hallmark of the FA pathway activation. Monoubiquitinated FANCI/D2 complex 
has presumed functions of recruiting DNA lesion-processing endonucleases (Kratz et al.; Liu 
et al.; MacKay et al.; Smogorzewska et al.) (Knipscheer et al., 2009) and transcriptional 
activation factor of tumor suppressor gene(s) (Park et al., 2013). For example, mono-
ubiquitinated FANCI/D2 enables the recruitment of FAN1 (named as FANCD2-associated 
nuclease). FAN1 is the virus-type replication-repair nuclease domain shown to have 5’-3’ 
exonuclease activity and structure-specific 5’-flap endonuclease activity. These activities 
enable FAN1 to unhook crosslinks in ICL repair (Kratz et al.; Liu et al.; MacKay et al.; 
Smogorzewska et al.).  
Although the FA core complex provides the key E3 ligase for FANCI/D2 
ubiquitination, understanding of most FA core components is limited to their presence in the 
core complex.  Studies have shown that FANCL containing the RING domain bears the E3 
ligase activity (Alpi et al., 2008; Meetei et al., 2003). Aside from that, most other 
components of the core complex do not have recognizable motifs or clearly defined functions 
regarding their contributions to the DNA damage induced FANCD2/I monoubiquitination. 
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Therefore, it is important to study the epistatic relationship among the FA core complex and 
define functions of each FA core component as to how they contribute to the FANC I/D2 
monoubiquitination and cellular response to DNA damage. 
Previous studies suggested that FA proteins form three distinct sub complexes A-G-
20, B-L-100, C-E-F (Ali et al.; Yan et al.) (Ling et al., 2007; Medhurst et al., 2006) (Leveille 
et al., 2004). These sub complexes and their functions in ICL-induced DNA damage response 
have not been revealed. FANCF binds to FANCM which might contribute to the loading of 
the core complex to the DNA damage sites (Deans and West, 2009). 
FANCM, a highly conserved helicase, has a DEAH helicase domain with ATP-
dependent DNA translocase activity (Hoadley et al.; Meetei et al., 2005). FANCM forms a 
complex with FAAP24 and the histone-fold protein MHF1/MHF2 (Ciccia et al., 2007; Yan et 
al.). This complex is important for recruiting the FA core complex to the ICL site (Kim et al., 
2008) and stabilizing and remodeling the stalled DNA replication forks (Gari et al., 2008a; 
Gari et al., 2008b; Yan et al.). Also, the FANCM/FAAP24 complex is suggested to play a 
role in ATR-mediated cell cycle checkpoint activation (Collis et al., 2008; Huang et al.; 
Schwab et al.) and to load the Bloom complex to the ICL sites to suppress sister chromatid 
exchange (Deans and West, 2009). FANCM is also involved in recombination-independent 
ICL repair by promoting PCNA ubiquitination thus facilitating the recruitment of NER factor 
ERCC1 to the ICL sites (Wang et al., 2013). 
Since the classical FA pathway is primarily conserved within vertebrates, genetic 
platforms such as drosophila and yeast could not be employed. Although FA knockout mouse 
models have been established, few of them showed the developmental abnormalities as FA 
patient, or bone marrow failure nor developed acute myeloid leukemia (Koomen et al., 2002; 
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Yang et al., 2001).  In this study, I generated a series of isogenic cells with single and double 
knockout of several key core complex genes in the human cell line HCT116, which allows 
the epistatic analysis in human cells and elucidation of the functions of the FA core 
components in an isogenic background. This chapter describes the generation of the 
knockout cell lines while the following chapters will describe the epistatic analysis and 
functional studies. 
 
Materials and Methods 
Cell culture 
Human colorectal carcinoma cell line (HCT116) and human embryonic kidney cell 
line 293T (HEK293T) were obtained from the American Type Culture Collection (ATCC). 
HCT116 cells and the somatic knockout derivatives were all cultured in Dulbecco's 
Modification of Eagles Medium (DMEM) plus 10% fetal calf serum (FBS) with humidified 
5% CO2 at 37°C.  
Targeting construct 
FANCG targeting vector was constructed with the USER cloning system (New 
England BioLabs). In detail, two homology arms (about 1.5 kb) were PCR amplified from 
parental HCT116 genomic DNA with the following primers (the underlined sequence were 
the specific primers, while the prefix sequences each with a uracil were for cloning purpose). 
FANCG Left arm forward: GGGAAAGUAGCAGTGCAAGTACAGAGCGGCAC 
FANCG Left arm reverse: GGAGACAUTGTTGGTCTTACAGACTGCTCCCCCA 
FANCG Right arm forward: GGTCCCAUACGAGGAGGTTGTAGGCTTGGAGC 
FANCG Right arm reverse: GGCATAGUGGCCCCCAGACTGGACAGACAGAA 
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The amplified homologous arms were resected by USER to give end overhangs and 
cloned into the digested modified pAAV-USER vector (triple Flag tag removed from the 
previous AAV-USER-3×FLAG-KI vector) with a floxed neomycin resistance gene (neo) 
cassette (Zhang et al., 2008) (Fig 2.1).  
rAAV-mediated gene targeting 
The recombinant adeno-associated virus (rAAV) was packaged by co-transfecting the 
targeting vector, pAAV-RC and pHelper plasmid into HEK293T cells. The viral stocks were 
obtained 3 days after transfection by a freeze-thaw lysis method. Briefly, cells were pelleted 
and lysed with 3 cycles of freeze in dry ice-ethanol bath for 10 min and thaw in 37 °C water 
bath for 10 min. After centrifugation the viral supernatant was used to infect the HCT116 
cells, which were then plated at low density 2 days later for single colony formation under 
G418 selection (1mg/ml).  
PCR screening 
About 14 days later, G418-resistant single colonies were picked into 96-well plate. 
Pools were made, genomic DNA of pools were prepared and screened for the gene targeting 
event with PCR with the following primers. Single colonies in the positive pool were 
screened with the Lyse-and-Go PCR reagents (Thermo Scientific). PCR primer pairs to 
detect positive targeting events were designed as one in the neo cassette, the other outside of 
the homologous arm to ensure the correct homology-mediated replacement (Fig 2.2).  
FANCG TAF: GCCCGGCCCCAGCGTATGAC 
FANCG TAR: GCGCATCGCCTTCTATCGCCTTCTTG 
neoS2: GCGGCATCAGAGCAGCCGATTGTCT 
3F1: GCGCATCGCCTTCTATCGCCTTCTTG 
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The positive clones were infected with Ade-Cre virus to remove the neo cassettes. 
After 1 day of incubation, cells were seeded in low density (about 100-200 cells/10cm plate), 
and then about 24 colonies were picked 14 days later. The colonies were screened by PCR 
for the complete removal of the neo cassette with the primers as follows: 
FANCG TAF: GCCCGGCCCCAGCGTATGAC 
FANCG KOR: CACCTGGACCAACACAGGCCG 
To target the second allele of FANCG, the heterozygous clones were infected with the 
targeting rAAV virus again. During the screening for positive targeting event, primers as 
following specific to amplify wild type FANCG was used to exclude re-targeting event.  
FANCG lossF: AGGATATCCAGCGGAGCCTAGAGAGAG 
FANCG lossR: GATGATCTATTCCAGCGTGCCTCCTCA 
Confirmed null clones were then infected with Ade-Cre virus to excise neo cassette. 
And PCR were carried out with the primers (named as FANCG KOF+KOR, FANCG 
lossF+lossR) to confirm the total loss of the target gene (Fig 2.3). 
Complementation of FA knock out cell lines 
For complementation purpose, FANCB- cells were transfected with Flag-FANCB 
cDNA in a pIRES-NEO3 vector.  FANCG-/- cells were transfected with pIRES-PURO3-
FANCG. The vector pIRES-PURO3 is modified by adding 3*Flag upstream of the MCS. 
FANCL-/- cells were transfected with pDEST-SFB-FANCL. 
Generation of double knockout cell lines  
FANCB was targeted in the FANCG-/- and FAAP20-/- cells to make the FANCG-/- 
FANCB- and FAAP20-/- FANCB- cells. FANCB targeting vector was constructed by a former 
lab member Yingjun Jiang with the same cloning system with the primers as the following.  
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FANCB Left arm forward: GGGAAAGUatatggtgagaggtaggagtctgg 
FANCB Left arm reverse: GGAGACAUtacttgtcttgcaactcactctcc 
FANCB Right arm forward: GGTCCCAUtctgagtacaacctgatggtgttt 
FANCB Right arm reverse: GGCATAGUtgtttttcccctaccatttcttta 
FANCB LF: aaaatccttgcccagcccaatgtca 
FANCB RR: gggattcaaacccagggtacgtgtg 
neoS2: GCGGCATCAGAGCAGCCGATTGTCT 
3F1: GCGCATCGCCTTCTATCGCCTTCTTG 
FANCB lossF: gctaaggcagagagtgggaaaccac 
FANCB lossR: agtcaccacactgctgtaagcagga 
To make FANCG-/-FANCM-/- cells, the FANCM targeting on the FANCG-/- was 
carried out as before (Wang et al., 2013). 
Western blot 
Cells were lysed by NETN buffer (150 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM 
EDTA, 0.5% Nonidet P-40, with complete Mini Protease Inhibitor Cocktail (Roche 
04693159001)) on ice for 30min. After centrifuging at 4°C, 14,000 rpm for 5min, the 
supernatants were collected as whole cell extracts. Protein concentration was measured by 
Bradford’s methods. The whole cell extracts with equal amount of total protein were boiled 
with SDS 2×loading buffer, boiled at 100°C heat block for 10min, short spun, brief vortexed, 
and loaded to SDS-PAGE gel for electrophoresis. Semi-dry transfer was applied with 
nitrocellulose membrane. The blots were blocked and incubated with primary antibody over 
night at 4°C. After washing, HRP-conjugated secondary antibody was applied at room 
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temperature for 1 hr. And then wash the membrane before exposure to enhanced 
chemiluminescence reagent (Amershanm Biosciences) and film development. 
Immunoprecipitation 
Whole cell lysates were obtained with NETN buffer. Protein concentration was 
measured by Bradford’s methods. Lysates with equal amount of total protein were incubated 
with protein G beads for 2 hour at 4°C. The pre-cleared sample were obtained by collecting 
the supernatant after centrifugation and incubated with specific immunoprecipitation 
antibody over night at 4°C. Then protein G beads were added and rotated for at least 1 hr. at 
4°C, after which the beads washed and were boiled with SDS sample buffer to collect the 
immunoprecipitates. 
Immunofluorescence Staining 
Cells were seeded on cover slips in 6-well plate with low density and then treated 
with MMC. After 24 hours of treatment, cells were washed with PBS, fixed with 3% 
formaldehyde, and permeabilized with 0.5% Triton buffer (20 mM HEPES pH7.4, 50 mM 
NaCl, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton-X-100). Samples were then incubated 
with 5% BSA buffer for blocking, then the specific primary and secondary antibodies each 
for 1 hour at room temperature. Finally the cover slips were mounted onto glass slides with 
VECTASHIELD® Mounting Media with DAPI (Vector Laboratories H-1200) and observed 
with Nikon Eclipse 90i fluorescence microscopy. 
Antibodies 
Anti-human FANCB, FANCM, FANCL, and FAAP20 was described previously 
(Meetei et al., 2005; Wang et al., 2013). The commercial antibodies used in this study are 
shown as follows, anti-human FANCD2 (Novus NB100-182); anti-human FANCG (Novus 
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NB100-2566); anti-β-tubulin (Sigma-Aldrich T4026); peroxidase-conjugated rabbit anti-
mouse (Jackson ImmunoResearch 315-035-048); peroxidase-conjugated goat anti-rabbit 
(Jackson ImmunoResearch 111-035-144); Fluorescein (FITC)-conjugated donkey anti-rabbit 
(Jackson ImmunoResearch 711-095-152).  
 
Results 
Targeting strategy of FANCG  
Homologous recombination mediated gene targeting was used to knockout FANCG in 
HCT116 cells. The target vector carried by rAAV contained a neo cassette for selection, 
flanked by two ~1.5kb homologous arms (Fig 2.1). Through homologous replacement, exon 
3 and 4 should be substituted by the neo cassette, leading to early frame shift mutation of 
FANCG gene and thus premature termination and disruption of FANCG expression. After 
excision of neo cassette by introduction of Ade-Cre virus, the heterozygous FANCG clone 
could be targeted again for the second allele and thus to make the FANCG null cell line.  
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Fig. 2.1 Schematics of homologous recombination-mediated targeting of FANCG in HCT116 
cell line.  
UTR: untranslated region; HA: homologous arm; TK: thymidine kinase gene promoter; Neo: 
neomycin resistance gene expression cassette; L-ITR: left inverted tandem repeats; R-ITR: 
right inverted tandem repeats. The number labeled on top of each exon is the exon name. 
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Generation of heterozygous FANCG+/- cell lines 
The FANCG targeting vector-containing rAAV stocks were used to infect HCT116 
cells, colonies after G418 selection were screened for positively-targeted clones by PCR with 
primers as indicated (Fig 2.2A). For FANCG first allele targeting, I have picked ~300 
colonies, and screened out 2 FANCG +/n clones, as shown (Fig 2.2B). 
One of the positive clones was expanded, exposed to Ad-Cre virus, plated at low 
density to obtain FANCG+/- clones. The viral stock had high titer, resulting in high frequency 
of positive excision events. As shown (Fig. 2.2C, D), 22 out of 24 colonies picked were 
positive. These FANCG+/- clones with neo cassette removed and genotyping confirmed (Fig. 
2.2C, D), were ready for second allele targeting.  
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Fig. 2.2 Generation of FANCG+/n and FANCG+/- clones. 
(A) PCR primers designed to screen for FANCG+/n clone. HA: homologous arm; TK: 
thymidine kinase promoter; Neo: neomycin resistance gene cassette. 
(B) PCR confirming the correct targeting of FANCG using FANCG TAF/neoS2 primer pair 
and 3F1/FANCG TAR primer pair. FANCG+/n clone #2 was used for the Cre excision.  
(C) PCR primers designed to screen for FANCG+/- clone. HA: homologous arm; TK: 
thymidine kinase promoter; Neo: neomycin resistance gene cassette. 
(D) PCR screening for FANCG+/- clone after Cre excision using FANCG TAF/KOR primer 
pair. As seen, out of 24 clones, only the neo cassettes of #10 and #11 were not excised. Δ, 
knockout allele. wt, wild type allele. 
MW, molecular weight size maker. 
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Generation of FANCGn/- somatic knockout cell lines 
One of the FANCG+/- clone was seeded for second allele targeting. After infected with 
the FANCG targeting vector containing rAAV virus, cells were again selected by G418. The 
resistant clones were picked and screened for positive targeting. Since both alleles can be 
targeted with equal frequency, re-targeting event should be excluded by PCR to confirm the 
complete disruption of both alleles (Fig 2.3A, B). In total, ~1000 colonies were screened, 4 
clones are positively targeted, from which only one was confirmed to be FANCGn/- clone by 
genotyping with wild type allele specific primers (Fig 2.3C, D).  
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Fig. 2.3 Generation of the FANCGn/- clone.  
(A) Primers designed for screening FANCG-/n clone identification. TK: thymidine kinase 
promoter; HA: homologous arm; Neo: neomycin resistance gene. 
(B) PCR genotyping of the FANCG-/n clones (#4), the retargeted FANCG+/n clones (#6) , and 
the non-targeted FANCG+/-(# 1, 2, 3, 5, 7, 8).  Δ, knockout allele. wt, wild type allele. 
(C) Primers designed to confirm the FANCG-/n clone. This primer pair was specific to the 
targeting sequence which should be replaced by neo cassette in targeted allele. 
(B) PCR genotyping of the FANCGwt clone, FANCG+/n clone, FANCG+/- clone, FANCGn/-, 
and non-template control (-, in which distilled water was amplified). Δ, knockout allele. wt, 
wild type allele. 
MW, molecular weight size marker. 
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Generation of FANCG-/- somatic knockout cell lines 
The FANCGn/- clone was infected with Ade-Cre virus and seeded in low density to 
obtain clones with the neo cassette removed (Fig 2.4A, B). Western blot was used to confirm 
the complete loss of FANCG expression in the FANCG-/- cells (Fig 2.4C).  
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Fig. 2.4 Generation of the FANCG-/- clone.  
(A) PCR screening for FANCG-/- clone with primer FANCG TAF+KOR. #4, #5, #12, and 
#19 could be FANCGn/-, while the rest are all FANCG-/-. Δ, knockout allele. wt, wild type 
allele. 
(B) PCR genotyping of the FANCGwt clone, FANCG+/- clone, two FANCG-/- clones, and non-
template control (-, in which distilled water was amplified).  Primers for PCR were indicated 
under the corresponding image. Δ, knockout allele. wt, wild type allele. 
(C) Western blots confirming the complete loss of FANCG expression in FANCG-/- cells. 
MW, molecular weight size marker. 
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Confirmation of FANCB- cell line and Generation of FAAP20-/- and FANCL-/- knockout 
cell line 
FANCB targeting was designed and done by Dr. Yingjun Jiang (a former postdoctoral 
researcher in Dr. Lei Li’s lab). Since FANCB gene is an X-linked gene and HCT116 cell line 
is derived from a male patient, Dr. Yingjun Jiang removed the only allele to generate the 
FANCB null mutant. As shown (Fig 2.5A), exon 3, the first coding exon was deleted through 
homologous recombination-mediated targeting strategy. To verify the loss of FANCB, I did 
IP-western as shown (Fig 2.5B). 
FAAP20 and FANCL targeting was designed and done by Dr. Justin Leung (a former 
postdoctoral fellow in Dr. Junjie Chen’s lab) (Leung et al.). I obtained the FAAP20n/- and 
FANCLn/- from him and added Ade-Cre virus to remove the neo cassette. As shown (Fig 
2.5C, D), I verified the genotype of FAAP20-/- and FANCL-/- clone by PCR and the 
corresponding protein loss by western blot. 
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Fig. 2.5 Generation of FANCB-, FAAP20-/-, and FANCL-/- cell lines. 
(A) Schematics of FANCB targeting strategy. UTR: untranslated region; HA: homologous 
arm; TK: thymidine kinase gene promoter; Neo: neomycin resistance gene expression 
cassette; L-ITR: left inverted tandem repeats; R-ITR: right inverted tandem repeats. The 
number labeled on top of each exon is the exon name. 
(B) IP-Western result showing complete loss of FANCB protein expression in the FANCB- 
cell line.  
(C) PCR result confirming the FAAP20-/- and FANCL-/- cell lines. Δ, knockout allele. wt, 
wild type allele.  
(D) Western result showing complete loss of FAAP20 and FANCL protein expression in the 
FAAP20-/- and FANCL-/- cell lines, respectively.  
MW, molecular weight size marker. 
 
38 
 
 
  
39 
 
Complementation of FA knock out cell lines 
In order to exclude the clonal effect of each FA knockout cell lines, complementation 
of the single knock out cell lines, FANCG-/-, FANCB-, and FANCL-/- was carried out. Full 
length FANCG, FANCB, and FANCL were introduced back to the corresponding mutant cell 
lines. Immunofluorescence staining was conducted to confirm that FANCD2 foci formation, 
a marker for the FA activation, could be restored when the deficient cell were complemented 
with the specific gene (Fig 2.6A-C).  
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Fig. 2.6 Complementation of FANCG-/-, FANCB-, and FANCL-/- single knockout cell lines. 
(A) Immunofluorescence staining for MMC-induced FANCD2 foci formation confirming the 
complementation of FANCG-/- cell line. GFL, full-length FANCG. 
(B) Immunofluorescence staining for MMC-induced FANCD2 foci formation confirming the 
complementation of FANCB- cell line.  BFL, full-length FANCB. 
(C) Immunofluorescence staining for MMC-induced FANCD2 foci formation confirming the 
complementation of FANCL-/- cell line. LFL, full-length FANCL. 
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Generation of FANCG-/- FANCB-, FAAP20-/- FANCB-, and FANCG-/- FANCM-/- somatic 
double knockout cell lines  
FANCB was targeted in the FANCG-/- and FAAP20-/- mutant cells to obtain the 
FANCG-/-FANCB- and FAAP20-/-FANCB- double mutants, respectively. FANCB targeting 
vector was constructed by a former lab member Yingjun Jiang with the same cloning system 
with the primers as shown before. The FANCB targeting efficiencies in FANCG-/- cells and 
FAAP20-/- cells were 2/500 clones and 7/1200 clones respectively.  The genotyping of 
representative cell lines were confirmed as shown (Fig 2.7A, B) 
To make FANCG-/-FANCM-/- cells, the FANCM targeting on the FANCG-/- was 
carried out as previously described (Wang et al., 2013). In the first allele targeting, one out of 
~400 screened clones was positive as FANCG-/-FANCMn/+. Following the standard 
procedure, Ade-Cre virus was added to remove the neo cassette. For the second allele target, 
one out of ~240 clones screened turned out to be FANCG-/-FANCMn/-.  Again, neo cassette 
was excised by Cre to generate the FANCG-/-FANCM-/- cell line (Fig 2.7C). Western blot was 
also used to verify the complete disruption of FANCM protein expression (Fig 2.7D). 
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Fig. 2.7 Generation of FANCG-/-FANCB-, FAAP20-/-FANCB-, and FANCG-/-FANCM-/- 
double knockout cell lines. 
(A) PCR genotyping of FANCG and FANCB in wt, FANCG-/-, FANCB-, and FANCG-/-
FANCB- clones. Δ, knockout allele. wt, wild type allele. 
(B) PCR genotyping of FAAP20 and FANCB in wt, FAAP20-/-, FANCB-, and FAAP20-/-
FANCB- clones. Δ, knockout allele. wt, wild type allele. 
(C) PCR genotyping of FANCG and FANCM in wt, FANCG-/-, FANCM-/-, and FANCG-/-
FANCM-/- clones. Δ, knockout allele. wt, wild type allele. 
(D) Western blot confirming complete protein loss of FANCG and FANCM in the FANCG-/-
FANCM-/- cell line. 
MW, molecular weight size maker 
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Discussion 
The FA core complex plays an essential role as the E3 ligase activity for FANCI/D2 
ubiquitination, which is the central event of the FA pathway activation in response to DNA 
damage. As the classical FA pathway is primarily conserved within vertebrates, genetic 
models such as yeast and drosophila could not be used. While mouse models with FA 
deficiency failed in generating phenotype compared to FA patients, the hypomorphic nature 
of mutations in FA patient cells prevents reliable functional readout of FA core components. 
Thus, I generated FANCG null human cell line in HCT116 background, which allows the 
functional study of FANCG in the FA pathway and cellular response to DNA damage.  
To conduct the epistatic study among FA genes, I took advantage of FANCM and 
FANCB previously established to construct FANCG-/-FANCB-, FAAP20-/-FANCB-, and 
FANCG-/-FANCM-/- cell lines. With these mutants, epistatic relationship among the FA core 
genes can be accessed by conducting functional studies on these cell lines comparing with 
wild type and the single mutants. 
As mentioned before, FANCG forms a sub complex with FANCA and FAAP20. 
FANCA has been suggested to have DNA binding activity (Yuan et al., 2012). FAAP20 was 
also proposed to anchor ubiquitinated histone to recruit the FA core complex (Yan et al.).  
The role of the A-G-20 sub complex in the loading of FA core complex is of particular 
interest to us. FANCG is considered as a scaffolding protein with seven TPR motifs (Blom et 
al., 2004; Hussain et al., 2006). A likely function is to maintain the integrity of the sub 
complex. By studying the epistasis of FANCG with other core component using the isogenic 
cell lines, we are able to determine whether FANCG has functions independent of the FA 
core complex and how it interacts genetically with other core complex components.  
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The advantage of our model lies on the isogenicity of the cell lines created (Rago et 
al., 2007). Compared with the patient cell line, our system provide a complete isogenic null 
background In contrast to siRNA/shRNA-based, off-target effect is minimum, since the long 
homologous arms make the targeted recombination highly specific. Although the HCT116  
cell line is immortalized and transformed from a colon cancer cell line, it is a stable diploid 
cell line with relatively normal background (Roschke et al., 2002). Despite the defined 
mutation in mismatch-repair gene MLH1, it has proficient machineries for all other DNA 
damage repair (Papadopoulos et al., 1994; Umar et al., 1994). These features make it suitable 
platform for DNA damage response, checkpoint and chromosomal stability studies. 
In conclusion, I have generated FANCG-/-, FANCG-/-FANCB-, FAAP20-/-FANCB-, and 
FANCG-/-FANCM-/- cell lines and employed the previously established FANCM, FAAP20, 
FANCL, and FANCB null mutants. Those models not only allow the precise functional 
studies of the FA core genes but also make it possible for epistatic analysis among FA core 
genes in a human cellular system.  
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CHAPTER III 
FANCL, FANCB, and FAAP100 Form the Catalytic Module of the FA Core Complex 
 
Introduction 
Upon DNA damage, signaling kinases such as ATM or ATR phosphorylate several 
FA proteins that contribute to the activation of the FA pathway. The FA core complex 
provide the E3 ligase activating the FA pathway through monoubiquitination of the 
FANCI/D2 complex on FANCD2 lysine 561 (Garcia-Higuera et al., 2001) and FANCI lysine 
523 (Smogorzewska et al., 2007), respectively. FANCI/D2 complex monoubiquitination is 
the key event of the FA pathway activation. The functions of this modified FANCI/D2 have 
been suggested to have nuclease activity (Pace et al., 2010), nucleosome chaperone and 
assembly activity (Sato et al., 2012), and transcriptional activity (Park et al., 2013). More 
directly related to DNA ICL repair, FANCI/D2 complex itself can recognize stalled forks or 
processed lesion (Joo et al.). And the monoubiquitinated FANCI/D2 are suggested to recruit 
downstream effectors, including endonucleases (Knipscheer et al., 2009; Kratz et al.; Liu et 
al.; MacKay et al.; Smogorzewska et al.). For the S-phase DNA interstrand cross link repair, 
ubiquitinated FANCI/D2 is required for the nucleolytic incisions near the lesion and 
translesion DNA synthesis bypassing the lesion (Knipscheer et al., 2009).  
One example of the endonuclease recruited to chromatin by the monoubiquitinated 
FANCI/D2 is FAN1, which has 5’-3’ exonuclease and 5’-flap structure-specific 
endonuclease activities (Liu et al.). With the FANCD2-dependent recruitment to the DNA 
damaged site, FAN1 is able to resect the exposed DNA ends and excise stalled replication 
fork structures. These properties might play a role in the crosslink unhooking step of the ICL 
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repair process by coordinating with other structure-specific nucleases such as  XPF-ERCC1 
and MUS81-EME1 (Kratz et al.; Liu et al.; MacKay et al.; Smogorzewska et al.). Another 
nuclease-related factor recruited by ubiquitinated FANCI/D2 is SLX4, or FANCP, which is a 
docking platform for structure-specific nucleases such as SLX1, XPF-ERCC1, and MUS81-
EME1 (Yamamoto et al., 2011). 
Transcription-regulatory activity of monoubiquitinated FANCI/D2 complex on tumor 
suppressor gene has been suggested. TP63, a p53 family member, promotes apoptosis and 
suppresses tumorigenesis. Monoubiquitinated FANCD2 was found to directly bind to the 
promoter region of TP63 gene and promotes the transcription of TP63, thus preventing 
tumorigenesis (Park et al., 2013). The ubiquitination deficient FANCD2 mutant K561R, 
however, lost its ability to bind to the promoter region and transactivate TP63 upon DNA 
damage and oncogene stimulation. 
Collectively, monoubiquitination of FANCD2 is the central event of the FA pathway 
activation. Monoubiquitinated FANCD2 can tether the upstream signaling and the 
downstream effectors for essential cellular response to DNA damage. Thus studying how the 
FANCD2 is ubiquitinated provides important insight into FA biology and the DNA repair 
mechanisms. 
As mentioned in Chapter I, FANC I/D2 is ubiquitinated by the FA core complex, 
which consists of A, G, C, E, F, B, L, and two FA associated protein FAAP100 and FAAP20. 
The relationships between FA core proteins have been shown to be very complicated 
(Hodson and Walden, 2012). It is generally suggested that FA core proteins form three sub 
complexes as shown (Fig. 3.2A). FANCA, FANCG, and FAAP20 form a sub complex (Ali 
et al.; Garcia-Higuera et al., 1999; Kruyt et al., 1999; Reuter et al., 2000; Waisfisz et al., 
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1999; Yan et al.). FANCB, FANCL, and FAAP100 form another sub complex (Ling et al., 
2007; Medhurst et al., 2006). It is still controversial whether FANCL or the B-L-100 sub 
complex is sufficient for FANCI/D2 ubiquitination or not, as in vitro studies indicating that 
FANCL itself was sufficient to ubiquitinate the FANCD2 (Longerich et al., 2009), whereas 
most studies showing that loss of the other FA core genes including A, B, C, E, F, G, and 
FAAP100 abolished the FANCI/D2 ubiquitination (Garcia-Higuera et al., 2001; Howlett et 
al., 2002; Ling et al., 2007; Meetei et al., 2004; Vandenberg et al., 2003; Yamamoto et al., 
2005). Another sub complex is composed of FANCC, FANCE, and FANCF (Leveille et al., 
2004; Leveille et al., 2006; Medhurst et al., 2001; Pace et al., 2002; Taniguchi and D'Andrea, 
2002). However, the specific roles of each sub complex in the FA core complex are still 
unclear. 
Although there are evidences shown that sub complexes exist in the core complex, 
understanding of most of the core components is still limited to their presence in the core 
complex. Except for FANCL which has been shown to have the RING domain bearing the 
E3 ligase activity (Alpi et al., 2008; Meetei et al., 2003), most of the FA core complex or the 
sub complexes do not have clearly defined functions contributing to ubiquitination action 
induced by DNA damage signaling. Therefore, our goal is to study the epistatic relationships 
among the FA core genes and define functions of each FA core component in the process of 
FANC I/D2 monoubiquitination and cellular response to DNA damage. Based on these, we 
hypothesized that the sub complexes exert differential functions contributing to the 
FANCI/D2 ubiquitination and ICL repair. To test our hypothesis, systematic epistatic 
analysis and functional studies were conducted to define the roles of the FA core genes 
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especially in resisting against DNA ICL damage and mediating the spatially defined 
monoubiquitination of FANCI/D2 complex.  
 
Materials and Methods 
Cell culture 
Human colorectal carcinoma cell line (HCT116) and the derived FA mutant cell lines 
were all cultured in Dulbecco's Modification of Eagles Medium (DMEM) plus 10% fetal calf 
serum (FBS) with humidified 5% CO2 at 37°C.  
DT40 wild type and knockout cells were generated via published procedures and 
cultured in RPMI-1640 medium plus 10% FBS, 1% chicken serum, 5µM 2-mercaptoethanol, 
and 10mM HEPES, at 39.5°C. 
Antibodies 
Anti-human FANCL, FAAP100, FAAP20, and FANCM antibody, and Anti-chicken 
FANCD2 was described previously (Ling et al., 2007; Meetei et al., 2003; Wang et al., 2013; 
Yamamoto et al., 2005; Yan et al.). The commercial antibodies are the following: anti-human 
FANCD2 (Abcam ab2187, Santa Cruz SC-20022, Novus NB100-182); anti-human FANCI 
(Bethyl A300-254A); anti-human FANCA (Bethyl A301-980A); anti-human FANCG 
(Novus NB100-2566); anti-histone H3 (Millipore 05-928); anti-β-tubulin (Sigma-Aldrich 
T4026); anti-FLAG M2 (Sigma-Aldrich F3165); peroxidase-conjugated rabbit anti-mouse 
(Jackson ImmunoResearch 315-035-048); peroxidase-conjugated goat anti-rabbit (Jackson 
ImmunoResearch 111-035-144). 
Immunoprecipitation 
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Whole cell lysates were obtained with NETN buffer. Protein concentration was 
measured by Bradford’s methods. Lysates with equal amount of total protein were incubated 
with protein G beads (Protein G Sepharose 4 Fast Flow, GE Healthcare 17-0618-01) for 2 
hour at 4°C. The precleared sample were obtained by collecting the supernatant after 
centrifugation and incubated with specific immunoprecipitation antibody over night at 4°C. 
Then protein G beads were added and rotated for at least 1 hr. at 4°C, after that the beads 
were washed, boiled with 2× Laemmli SDS sample buffer, and pelleted. The supernatants 
were collected as immunoprecipitates. 
Gel filtration 
To obtain the nuclear cell extracts for gel filtration, cells were incubated in hypotonic 
buffer (10 mM Tris, pH 7.4, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM Dithiothreitol, and 
protease inhibitors (Roche 04693159001)) on ice. After 10 min, NP-40 (0.1% final 
concentration) was added and nuclei were pelleted by 10-sec centrifugation at 5,500 × g. 
After washing three times with hypotonic buffer, the nuclei were lysed in nuclear extract 
buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 1 mM 
EDTA, 1 mM Dithiothreitol , and protease inhibitors). Subsequently, the nuclear extract 
(about 2 mg total protein) was applied directly to a Superose 6 10/300 GL column (GE 
Healthcare 17-5172-01). The fractions of 0.4ml were collected and analyzed by western blot. 
Chromatin fractionation 
To obtain chromatin-bound protein fraction, cells were lysed with NETN buffer (100 
mM NaCl, 20 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5% Nonidet P-40, with cOmplete 
Mini Protease Inhibitor Cocktail Tablet (Roche Applied Science 11836153001)) at 4 °C for 
30 min and centrifuged for 30 min at 14,000 rpm for collection of the insoluble pellet. The 
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soluble fraction was collected as the soluble fraction. The insoluble fraction was then lysed 
with 0.2 N HCl for 30 min on ice and centrifuged for 30 min at 14,000 rpm. The supernatant 
was later neutralized with 1 N Tris-HCl (pH 8.0) and collected as the chromatin fraction. 
Western blot 
Cells were lysed by NETN buffer (150 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM 
EDTA, 0.5% Nonidet P-40, with complete Mini Protease Inhibitor Cocktail (Roche 
04693159001)) on ice for 30min. After centrifuging at 4°C, 14,000 rpm for 5min, the 
supernatants were collected as whole cell extracts. Protein concentration was measured by 
Bradford’s methods. The whole cell extracts with equal amount of total protein were boiled 
with SDS 2×loading buffer, boiled at 100°C heat block for 10min, short spun, brief vortexed, 
and loaded to SDS-PAGE gel for electrophoresis. Semi-dry transfer was applied with 
nitrocellulose membrane afterwards. The blots were blocked and incubated with primary 
antibody over night at 4°C. After washing, HRP-conjugated secondary antibody was applied 
at room temperature for 1 hr. And then wash the membrane before exposure to enhanced 
chemiluminescence reagent (Amershanm Biosciences) and film development. 
Clonogenic survival assay 
Equal amount of cells were seeded in 100 mm culture plate. The next day, cells were 
exposed to ICL damage agents at different dosages for 1 hr. After that, cells were washed, 
trypsinized, and seeded with appropriate cell number in 100 mm culture plates, by triplicates 
per dosage per cell line. After grown for approximately 14 days, colonies were fixed by 
glutaraldehyde 6.0% (v/v) and stained with 0.5% crystal violet (w/v) in ethanol. Colonies 
about 50-200 per plate were counted and used to calculate the relative survival with the 
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following equation: % survival = # of colonies counted / (# of cells plated × plating 
efficiency) × 100. 
Mitotic spread and cytogenetic analysis 
For spontaneous and MMC-induced chromosomal abnormality analysis, cells were 
grown in low density and mocked treated or treated with 20 ng/ml MMC for 18 hrs. Cells 
were collected after colcemid treatment (0.1 μg/ml) for 1 hr. Cells were then swelled in 
hypotonic solution (0.075M KCl) at RT for 15 min and then fixed by methanol: acetic acid 
(3:1).  The fixed cells were dropped into slides and stained with 4% Giemsa. Chromosomal 
abnormalities were quantified under bright field microscope by scoring more than 50 
metaphases per sample. 
 
Results 
Confirmation of sub complexes in the FA core complex  
To investigate the function of each protein in cellular response to ICL DNA damage, 
we created FANCG-/- and FANCB- knockout mutants via homology-mediated replacement 
targeting in HCT116 cell line as mentioned in Chapter II. The strict isogenicity among these 
knockout mutants allows direct comparison of protein functions.  
To further verify the existence of the sub complexes in the FA core complex, protein-
protein interdependency and interaction were analyzed with the FANCG-/-, FANCB-, FANCL-
/-, and FAAP20-/- cell lines. As shown in Fig 3.1A, FANCG knockout significantly reduced 
the level of FANCA and FAAP20, and FAAP20 deficiency decreased the level of FANCA. 
On the other hand, FANCL and FAAP100 level was greatly reduced in FANCB- cells. 
Immunoprecipitation studies showed that the A-G-20 sub complex still existed in the absence 
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of FANCB or FANCL, in that the interaction between FANCA and FANCG or FANCA and 
FAAP20 remained in FANCB and FANCL null cells (Fig. 3.1B). On the other hand, the B-
L-100 sub complex remains intact in the absence of FANCG or FAAP20, in that the 
interaction between FANCL and FAAP100 remained in FANCG and FAAP20 null cells 
(Fig. 3.1C). Similar results were obtained in the condition of MMC treatment (data not 
shown). In summary, our study demonstrated that the A-G-20 and B-L-100 sub complexes 
physically presented in the human cells. If one of the sub complexes collapsed, the other still 
existed and might function in the ICL induced cellular response. 
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Fig. 3.1 Formation of sub modules within the FA core complex.  
(A) Immunoblot detecting FA core complex protein levels in FANCG-/-, FANCB-, FANCL-/-, 
and FAAP20-/- knockout mutant cells. Whole cell extracts were prepared from unperturbed 
mutant cell lines in human HCT116 background. Protein stability interdependencies are 
observed in the FANCG-/-, FANCB-, and FANCL-/- mutants.  
(B) Co-immunoprecipitation of FANCA in FANCG-/-, FANCB-, FANCL-/-, and FAAP20-/- 
mutants, indicating the presence of the A-G-20 sub module.  
(C) Co-immunoprecipitation of FANCL in FANCG-/-, FANCB-, FANCL-/-, and FAAP20-/- 
mutants, indicating the presence of the B-L-100 module.  
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FA core complex is not an integral complex 
Previous literatures and our protein-protein inter-dependency and interaction studies 
in the knockout mutant have collectively defined the three sub complexes inside the FA core 
complex (Fig. 3.2A). To verify whether deletion of individual core component impact the 
overall integrity of the core, gel filtration chromatography was carried out and determined the 
size of the core. As shown (Fig. 3.2B), deletion of FANCG and FANCL did not result in a 
gross disruption of the core complex, as reflected by the similar elution positions of the 
mutant core components to that of the wild type FA core complex (670kD). Nevertheless, it 
cannot be excluded that certain core component(s) may be accounted for retaining the overall 
complex integrity (Gordon et al., 2005). To verify the presence of such structural 
component(s), additional studies are required. 
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Fig. 3.2 FA core complex is not an integral complex.  
(A) Depiction of three modules inside the FA core complex.  
(B) Superose 6 gel filtration profiling of the core complex in WT, FANCL-/-, and FANCG-/- 
mutants. Immunoblotting of FAAP100 and FANCL in the indicated fractions shows that the 
elution volumes of the core complex in wild type and mutant cells are largely consistent, 
suggesting that the integrity of the core complex is not overly disrupted by the deletion of 
FANCG or FANCL. Fraction 21 marks the void. 
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Identification of the B-L-100 catalytic module in the FA core complex  
Loss of FANCB leads to marked decreased protein level of FANCL (Fig. 3.1A), 
which is previously shown to bear the E3 ligase activity for FANCD2 monoubiquitination. 
Thus it is plausible that FANCB also plays a more essential role than FANCG in impacting 
the level of FANCD2 monoubiquitination. To evaluate this hypothesis, we examined a panel 
of human cellular knockout mutants for DNA damage-induced FANCD2 monoubiquitination 
from whole cell extracts, except for FAAP20, most mutant showed a significantly reduced 
FANCD2 monoubiquitination. However, in the chromatin fractions prepared from cells 
exposed to mitomycin C where ubiquitinated form of FANCD2 is enriched, mutants devoid 
of FANCL, and FANCB exhibited complete loss of FANCD2 and FANCI 
monoubiquitination, whereas loss of G, and FAAP20 showed readily detectable levels of 
FANCD2 and FANCI monoubiquitination (Fig.3.3A). This was consistent in cisplatin treated 
cells (Fig.3.3B).  
To confirm this result, DT40 FA mutant cells were tested for FANCD2 
ubiquitination. As shown (Fig. 3.3C), FANCL and FAAP100 knockout led to complete 
ablation of monoubiquitinated FANCD2, while FANCA, G, E, and FAAP20 deficiency did 
not completely abolish the ubiquitination. This result suggests that FANCL, B, and 
FAAP100 constitute a catalytic core, which is absolutely essential for the E3 ligase activity 
of the FA core complex. 
 To exclude the possibility of differential FANCD2 total protein loss in the knockout 
mutants, chromatin-bound, soluble protein fractions, and whole cell extracts were tested for 
their FANCD2 levels and confirmed that each contained the same amount of total FANCD2 
as the parental HCT116 or DT40 cells (Fig. 3.4). Thus FANCB, FANCL, and FAAP100 
61 
 
most likely form a highly integrated module as demonstrated by a strong interdependency of 
protein stabilities. On the other hand, the A-G-20 and C-E-F modules appear to play auxiliary 
roles in FA core complex function.   
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Fig. 3.3 FANCL, FANCB, and FAAP100 form the catalytic module of the FA core complex. 
(A) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 and FANCL in 
wild type (WT) and the indicated knockout mutants in human HCT116 background.  
(B) Immunoblot detecting cisplatin-induced monoubiquitination of FANCD2 in wild type 
(WT) and indicated knockout mutants in human HCT116 background.  
(C) Immunoblot detecting MMC- and cisplatin-induced monoubiquitination of FANCD2 in 
wild type (WT) and indicated knockout mutants in chicken DT40 background.   
*FANCG gene localizes in the single Z chromosome and thus DT40 cell only have one 
FANCG allele. 
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Fig. 3.4 FANCD2 levels in HCT116 and DT40 knockout mutants 
(A) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 in wild type (WT) 
and the indicated knockout mutants in human HCT116 background.  
(B) Immunoblot detecting cisplatin-induced monoubiquitination of FANCD2 in wild type 
(WT) and indicated knockout mutants in human HCT116 background.  
(C) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 in wild type (WT) 
and indicated knockout mutants in chicken DT40 background.  
(D) Immunoblot detecting cisplatin-induced monoubiquitination of FANCD2 in wild type 
(WT) and indicated knockout mutants in chicken DT40 background.  
Tubulin and Histone H3 are used as loading and extraction controls. 
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B-L-100 sub complex is more critical for cellular resistance to MMC than the A-G-20 
sub complex 
Since FANCD2 monoubiquitination is the central event for the FA pathway 
activation, which functions in the cellular resistance to ICL DNA damage, and B-L-100 is the 
catalytic core module of the FA core complex, it is predicted that  mutants from this module 
leads to stronger damage sensitivity compared with other mutants from FA core complex. To 
test this premise, we compared four isogenic knockout mutants (Fig. 3.5A) for their 
crosslinking damage sensitivity and observed that loss of FANCL or FANCB rendered 
comparable but much more severe phenotypes than loss of FANCG or FAAP20. The variant 
degree of sensitivities from distinct components of the core complex seems to indicate 
distinct functions executed by the two different protein modules in maintaining genomic 
integrity of the cells in response to DNA damage. Indeed, the chromosomal analysis showed 
that FANCL or FANCB was more important in protecting cells from genomic instability than 
FANCG or FAAP20 as expected (Fig. 3.5B). 
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Fig. 3.5 B-L-100 sub complex is more essential for the cellular resistance to MMC than A-G-
20 sub complex.  
(A) Clonogenic survival of FAAP20-/-, FANCG-/-, FANCB-, and FANCL-/- mutants treated 
with mitomycin C. Error bars were derived from SDs from 4-6 independent experiments with 
triplicated plates.  
(B) Chromosomal aberration counts in FAAP20-/-, FANCG-/-, FANCB-, and FANCL-/- mutants 
treated with mitomycin C. Error bars are derived from DSs from more than 50 counts per cell 
line. 
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B-L-100 sub complex is epistatic to A-G-20 sub complex in cellular resistance to ICLs 
To test the epistatic relationship among the FA core genes, clonogenic survival assay 
was carried out. As shown (Fig. 3.6A), the FANCG-/- mutant is significantly more resistant 
than FANCB- to crosslinking DNA damage, while deletion of both genes did not acquire any 
additional sensitivity compared to FANCB-. The differential sensitivities suggest that 
FANCB plays an epistatic yet more important role than FANCG in cellular resistance to 
crosslinking DNA damage. This is also confirmed in other crosslinking agent treatment 
experiment such as cisplatin and formaldehyde (Fig. 3.6C and D). Given that FANCG and 
FAAP20 reside in the same module, we tested FAAP20-/-FANCB- knockout mutants (Fig. 
3.6B) and observed a similar survival profile, which implicates an epistatic but more 
essential function of FANCB in cellular resistance to crosslinking reagents.  
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Fig. 3.6 B-L-100 sub complex is epistatic to A-G-20 sub complex in cellular resistance to 
ICLs.  
(A) Clonogenic survival of FANCB-, FANCG-/-, and FANCB-G-/- mutants treated with 
mitomycin C.  
(B) Clonogenic survival of isogenic FANCB-, FAAP20-/-, and FANCB-FAAP20-/- mutants 
treated with mitomycin.  
(C) Clonogenic survival of FANCB-, FANCG-/-, and FANCB-FANCG-/- mutants treated with 
cisplatin.  
(D) Clonogenic survival of FANCB-, FANCG-/-, and FANCB-FANCG-/- mutants treated with 
formaldehyde. 
Error bars were derived from SDs from four independent experiments with triplicated plates. 
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Discussion 
In conclusion, our study showed that FA core genes play differential roles in ICL 
damage resistance based on their presence in different sub complexes. This is the first study 
to demonstrate that FA core complex is not working as an integral complex. Instead, it can be 
dissected into sub complexes/modules according to protein interaction and functional 
differences. Specifically, B-L-100 sub module is indispensable for FANCI/D2 ubiquitination 
while A-G-20 and C-E-F are less important. In addition, genetic study also defined that A-G-
20 is epistatic with B-L-100 sub module.  
Our study is consistent with previous in vitro studies that FANCL is essential to 
ubiquitinate the FANCD2, while the intactness of the core complex is not essential 
(Longerich et al., 2009). The essential role of FANCB and FAAP100 in FA pathway 
activation lies in the fact that they stabilize the E3 ligase FANCL by forming a sub complex 
to maintain a stable level of FANCL. Our finding diverged from the current paradigm that 
each of the core complex submit is absolutely essential for the E3 ligase of the core. This is 
achieved from using epistasis analyses and functional readout of cell survival.  
Furthermore, our study further validated the notion that functional sub complexes 
exist in the core complex, A-G-20, B-L-100, and C-E-F sub complexes (Leveille et al., 2004; 
Ling et al., 2007; Medhurst et al., 2006; Yan et al.). B-L-100 sub complex is identified as the 
catalytic core module of the FA core complex. The accessory roles of A-G-20 and C-E-F sub 
complexes play in the FA pathway are addressed in the following Chapter IV.  
As to the study of sub complex, we notice that even in the same sub complexes the 
binding strength and dependence among components varies. For example, FANCG and 
FANCA are more tightly bound compared with FAAP20 and FANCG or FAAP20 and 
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FANCA. The effect of FAAP20 knockout on FANCA level is intermediate compared with 
FANCG knockout, while FANCG level is not affected apparently by FAAP20 deficiency 
(Fig. 3.1A). This indicates that FANCA and FANCG consists the core of the sub complex. 
Similarly, FANCB-FANCL and FANCB-FAAP100 are more closely bound compared with 
FANCL-FAAP100, as FAAP100 level is not significantly affected by FANCL depletion 
(Fig. 3.1C).  
Our study also shed new light on the disease etiology and biology of FA in different 
subtypes. The differential sensitivities of different FA core subunit genes may explain the 
different prevalence of the corresponding gene mutation among FA patients. In FA 
complementation subtypes, FANCA, FANCG, and FANCC have high frequency 
distribution, as 63%, 9%, and 12% respectively among all the FA patients genetically defined 
while FANCB and FANCL mutations accounts for less and  2% and 0.1%, respectively 
(Table 1.1 in Chapter I). Such a profound variation in complementation group distribution 
may be a strong reflection of their functions in FANCD2 monoubiquitination and cellular 
sensitivity against DNA crosslinking agents.  
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CHAPTER IV 
Chromatin Anchoring and Loading Modules Are Required 
For Full Function of FA Core Complex 
 
Introduction 
The major role of the core complex in FA pathway is to catalyze the 
monoubiquitination of the FANCI/D2 complex. FANCI/D2 complex ubiquitination is the 
core of the FA pathway activation. The function of the monoubiquitinated FANCI/D2 
complex is thought to recruit downstream factors to execute DNA damage repair process in 
response to ICL DNA damage, such as nucleases to repair ICLs (Liu et al.; MacKay et al.). 
However, how each of the core complex subunit functions in the ubiquitination reaction 
remains unclear except for the FANCL protein.  
As shown in the previous Chapter (Chapter III, Fig. 3.1 & 3.2), we have found that 
the FA core complex that the formation of one sub complex, which depends on protein-
protein interaction, does not depend on other FA core components. Moreover, in the FA core 
complex, only the B-L-100 sub complex is essential for the catalytic activity and more 
crucial for the cellular resistance to ICL DNA damage compared to the other two sub 
complexes. This is consistent with previous findings that FANCL with a RING domain bears 
E3 ligase activity and is essential to ubiquitinate the FANCI/D2 complex in vitro (Longerich 
et al., 2009). Then the next question is why vertebrate system needs many other components 
to execute the function. 
Our previous results show that the A-G-20 and C-E-F sub complexes likely provide 
accessory role in the FA pathway. This is reflected by not only the residual levels of 
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FANCD2 ubiquitination but also the less severe ICL DNA damage sensitivity in the 
FANCA, FANCG, FAAP20, and FANCE deficient cell lines (Chapter III, Fig. 3.3 & 3.4). 
Therefore, this Chapter focuses on deciphering the functions of A-G-20 and C-E-F 
complexes in the FA pathway activation and ICL DNA response, specifically how they 
facilitate FANCI/D2 ubiquitination. 
A major unanswered question in the FA pathway is how the FA core complex is 
recruited to the damaged site to initiate the ubiquitination reaction. FANCM has been showed 
by our group to play a role in loading the core complex to the damaged DNA site (Wang et 
al., 2013). FANCM was initially named FAAP250, as an FA associated protein during 
FANCA tandem affinity purification. It was first found to be mutated in a Fanconi anemia 
patient in 2005 and therefore identified as a FA gene (Meetei et al., 2005). It has highly 
conserved helicase domain with DNA translocase activity (Meetei et al., 2005). FANCM 
forms a complex with another FA associated protein, FAAP24 and the MHF1/MHF2 
histone-fold complex.  
It is proposed that FANCM complex interacts with and targets the FA core complex 
to chromatin (Thompson and Hinz, 2009). This model is supported by the DNA binding 
activities of FAAP24 and MHF complex. Indeed, FANCM is demonstrated in vivo to 
constitutively associates with chromatin, and the FANCM/FAAP24 complex can load the FA 
core complex to chromatin together with FAAP24, in response to DNA damage (Kim et al., 
2008). The MHF proteins are also shown to possess DNA binding activity, thus they 
facilitate the DNA interaction of FANCM and promote the FA pathway activation (Singh et 
al., 2010; Yan et al.). Together, FANCM appears important for the FANCD2 ubiquitination 
as other FA core genes by controlling the chromatin-loading of the whole core complex. 
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However, results from our lab and others showed that FANCM  is not essential in the 
activation of the FA pathway which is indicated by the considerate amount of ubiquitinated 
FANCD2 and the very mild phenotype in the deficient cell lines (Bakker et al., 2009; Wang 
et al., 2013). This indicates that additional factors may be involved in the recruitment of the 
FA core especially the catalytic B-L-100 sub complex to the damaged site for the full 
function of the FA core complex. The C-E-F sub complex is closely associated with 
FANCM, the MM2 motif of FANCM binds to the N-terminal 158 aa motif of FANCF 
(Deans and West, 2009). This is consistent with the previous finding that FANCF serves as 
an adapter for the core complex function (Leveille et al., 2004) and that FANCE is not 
essential for FANCD2 ubiquitination as shown in Chapter III. Thus it is likely that C-E-F is 
at least involved in the FANCM mediated initial loading of the FA core complex and there 
should be other factors functioning independently with FANCM.  
In the A-G-20 sub complex. FAAP20 is an FA associated protein discovered that 
contribute to the stabilization of the FANCA and its UBZ domain has been shown to binding 
to DNA damage-induced H2A polyubiquitination (Ali et al.; Leung et al.; Yan et al.). 
FANCA has direct DNA binding affinity (Yuan et al., 2012). Thus we hypothesized that A-
G-20 together also play a role in recruiting FANCL to the chromatin and the DNA damaged 
site independently of FANCM and the C-E-F sub complex. To test the hypothesis, 
chromatin-bound FANCL and the enrichment of FANCL to the ICL sites were analyzed in 
FA knockout and knockdown cells. 
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Materials and Methods 
Cell culture 
Human embryonic kidney cell line HEK293T, human colorectal carcinoma cell line 
HCT116 and the derived FA mutant cell lines were all cultured in Dulbecco's Modification 
of Eagles Medium (DMEM) plus 10% fetal calf serum (FBS) with humidified 5% CO2 at 
37°C.  
shRNA 
GIPZ lentiviral shRNA plasmids were purchased from the ShRNA and ORFeome 
Core, the University of Texas MD Anderson Cancer Center. The mature antisense sequences 
of FANCF shRNAs are ACTTCAAAATCTCCATCCT (#1), TGGGTTCTCTCTATAGCCA 
(#2), TTCTGAAGGTCATAGTGCA (#3), and TGGAGTGTCTCCTCATCGG (#4).  
Lentiviruses were packaged in HEK293T cells and then used to transduce cells. Stable cell 
lines were obtained after puromycin selection (2ug/ml). 
Antibodies 
Antibodies against human FANCL and FANCM and chicken FANCD2 were 
described previously (Meetei et al., 2003; Wang et al., 2013; Yamamoto et al., 2005). The 
commercial antibodies are from the following sources: anti-human FANCD2 (Abcam 
ab2187, Santa Cruz SC-20022); anti-human FANCI (Bethyl A300-254A); anti-human 
FANCG (Novus NB100-2566); anti-histone H3 (Millipore 05-928); anti-β-tubulin (Sigma-
Aldrich T4026); anti-FLAG M2 (Sigma-Aldrich F3165); anti-Myc (Santa Cruz SC-40); 
peroxidase-conjugated rabbit anti-mouse (Jackson ImmunoResearch 315-035-048); 
peroxidase-conjugated goat anti-rabbit (Jackson ImmunoResearch 111-035-144). 
Chromatin fractionation 
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To obtain chromatin-bound protein fraction, cells were lysed with NETN buffer (100 
mM NaCl, 20 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5% Nonidet P-40, with cOmplete 
Mini Protease Inhibitor Cocktail Tablet (Roche Applied Science 11836153001)) at 4 °C for 
30 min and centrifuged for 30 min at 14,000 rpm for collection of the insoluble pellet. The 
soluble fraction was collected as the cytosol and soluble nuclear part. The insoluble fraction 
was then lysed with 0.2 N HCl for 30 min on ice and centrifuged for 30 min at 14,000 rpm. 
The supernatant containing chromatin-bound proteins was neutralized with 1 N Tris-HCl (pH 
8.0). 
Streptavidin Sepharose pull-down assay 
Whole cell lysates were obtained with NETN buffer. Protein concentration was 
measured by the Bradford assay. Lysates with equal amount of total protein were incubated 
with protein G beads (Protein G Sepharose 4 Fast Flow, GE Healthcare 17-0618-01) for 2 
hour at 4°C. The precleared sample were then obtained by collecting the supernatant after 
centrifugation and incubated with Streptavidin Sepharose® High Performance Beads (GE 
Healthcare 17-5113-01) over night at 4°C. After that, the beads were washed, boiled with 2× 
Laemmli SDS sample buffer, and pelleted. The supernatants were collected for western blot. 
Western blot 
Cells were lysed by NETN buffer (150 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM 
EDTA, 0.5% Nonidet P-40, with complete Mini Protease Inhibitor Cocktail (Roche 
04693159001)) on ice for 30min. After centrifuging at 4°C, 14,000 rpm for 5min, the 
supernatants were collected as whole cell extracts. Protein concentration was measured by 
Bradford’s methods. The whole cell extracts with equal amount of total protein were boiled 
with SDS 2×loading buffer, boiled at 100°C heat block for 10min, short spun, brief vortexed, 
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and loaded to SDS-PAGE gel for electrophoresis. Semi-dry transfer was applied with 
nitrocellulose membrane afterwards. The blots were blocked and incubated with primary 
antibody over night at 4°C. After washing, HRP-conjugated secondary antibody was applied 
at room temperature for 1 hr. And then wash the membrane before exposure to enhanced 
chemiluminescence reagent (Amershanm Biosciences) and film development. 
Clonogenic survival assay 
Equal amount of cells were seeded in 100 mm culture plate. The next day, cells were 
exposed to ICL damage agents at different dosages for 1 hr. After that, cells were washed, 
trypsinized, and seeded with appropriate cell number in 100 mm culture plates, by triplicates 
per dosage per cell line. After grown for approximately 14 days, colonies were fixed by 
glutaraldehyde 6.0% (v/v) and stained with 0.5% crystal violet (w/v) in ethanol. Colonies 
about 50-200 per plate were counted and used to calculate the relative survival with the 
following equation: % survival = # of colonies counted / (# of cells plated × plating 
efficiency) × 100. 
eChIP assay 
The eChIP assay was done as previously described (Shen et al., 2009). Briefly, cells 
are transfected by electroporation with control, psoralen-induced ICL- or cisplatin-induced 
ICL- containing plasmid. 4-6 hours later, the attached cells were lysed, sonicated, and 
preceded to immunoprecipitation with specific antibody. The precipitates were used for DNA 
extraction and real-time PCR to detect the enrichment of specific protein at the ICL site. The 
cisplatin-adducted plasmid substrate was prepared by incubating with 15 µM cisplatin at 
37°C in the dark for 3 hrs. The cisplatin treatment induced on average 3 ICL/kb. 
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Results 
FANCG is important for FANCL chromatin loading 
To examine if A-G-20 sub complex is required for FANCL chromatin recruitment, 
we performed chromatin fractionation in FANCB-, FANCG-/-, and FANCL-/- mutant cells 
(Fig. 4.1A). As expected, there was much reduced FANCL chromatin loading in FANCB- 
mutant because of its reduced FANCL protein level as shown before. However, despite 
normal FANCL protein abundance, chromatin bound FANCL level in FANCG-/- was 
drastically reduced.  Quantitative analysis showed that it was approximately 10% of the wild 
type cells (Fig. 4.1B). This result indicates that the chromatin retention of the E3 ligase 
FANCL relies largely on FANCG.  Knockout of FAAP20 led to partial loss of FANCL 
chromatin binding, suggesting a minor role of FAAP20 in FANCL chromatin association. 
Conversely, the chromatin binding of FANCG maintained a significant level in FANCB- and 
FANCL-/- mutant cells, although a bit weakened compared to wild type cells (Fig. 4.1A, C). 
Therefore, it appears that the A-G-20 module plays a role s in the binding of the FANCL-
based catalytic sub complex to chromatin and anchors it to the site of DNA lesions.   
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Fig. 4.1 FANCG is important for FANCL chromatin loading.  
(A) Immunoblot detects the FANCL and FANCG protein in chromatin fractions in wild type 
(WT) and indicated mutants exposed to mitomycin C. Histone H3 serves as a loading control 
for chromatin-bound protein fractions.  
(B) Quantification of chromatin-bound FANCG in FANCB-, G-/-, L-/-, and FAAP20-/- 
knockout mutants.  
(C) Quantification of chromatin-bound FANCL in FANCB-, G-/-, L-/-, and FAAP20-/- 
knockout mutants. Error bars for chromatin fraction represent SDs derived from three 
independent experiments. 
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FANCG is important for FANCL recruitment to ICL sites 
To investigate the recruitment of FANCL and FANCG to the ICL sites, we performed 
the eChIP (Shen et al., 2009) assay with psoralen-induced DNA ICL substrates in the 
FANCL-/- and FANCG-/- mutants, respectively. Consistent with the chromatin fractionation 
results, we found that ICL-induced FANCG enrichment did not require FANCL (Fig. 4.2A), 
while enrichment of FANCL strongly depended on FANCG (Fig. 4.2C). To confirm this 
finding, cisplatin-induced ICL substrate was used in the eChIP assay and a similar result was 
obtained (Fig. 4.2B, D). These results collectively support that the A-G-20 module anchors 
the FA core complex to the DNA damaged sites. Moreover, the residual FANCL chromatin 
loading in the FANCG-/- mutant also implicates that, aside from FANCG, a separate factor, 
most likely FANCM, acts in the chromatin recruitment of FANCL. 
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Fig. 4.2 FANCG is important for FANCL recruitment to ICL sites.  
(A) eChIP analysis of FANCG enrichment to a defined psoralen lesion in wild type (WT) and 
FANCL-/- mutant.  
(B) eChIP analysis of FANCG enrichment to a cisplatin-adducted plasmid substrate in wild 
type (WT) and FANCL-/- mutant.  
(C) eChIP analysis of FANCL enrichment to a defined psoralen lesion in wild type (WT) and 
FANCG-/- mutant.  
(D) eChIP analysis of FANCL enrichment to a cisplatin-adducted plasmid substrate in wild 
type (WT) and FANCG-/- mutant.  
Error bars for eChIP analyses represent SDs derived from three independent experiments. 
  
85 
 
  
 
 
 
 
 
 
 
 
86 
 
Generation of FANCF stable knockdown cell lines 
Previous studies have implied that C-E-F may function in placing the FA catalytic 
core to the chromatin, since FANCF interacts with the FANCM/FAAP24 complex, C-E-F 
may serve as a chromatin-loading element for the FA core complex (Deans and West, 2009). 
To test this hypothesis functionally, a cell line with disrupted C-E-F module is necessary. 
Despite repeated efforts on targeting FANCC, I was unable to delete the second allele of 
FANCC in HCT116 cells. Thus, I employed the lentivirus-mediated shRNA technology to 
knockdown FANCF.   
As shown (Fig. 4.3A), four lentiviral shRNAs with different targeting sequences were 
screened and the one with the highest efficiency of knockdown was used to generate the 
FANCF stable knockdown cell in HCT116 cells. To confirm the specificity of this shRNA 
and exclude off-target effects, complementation experiments were carried by introducing full 
length human myc-tagged FANCF into the knockdown cell lines to show rescue of 
FANCD2/I ubiquitination and cellular sensitivity to ICL reagents (Fig. 4.3B-E). In order to 
study the epistatic relationship between C-E-F and A-G-20 or C-E-F and FANCM, FANCF 
was also stably knocked down in the FANCG and FANCM mutants (Fig. 4.3D-E). 
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Fig. 4.3 Generation of FANCF shRNA knockdown cell lines.  
(A) Screening of FANCF shRNAs. Four Lentivirus (#1 to #4) shRNA to FANCF were used 
to infect 293T cells stably expressing Myc-tagged FANCF. The Myc-tagged FANCF stable 
line was constructed to circumvent the lack of effective FANCF antibody. Immunoblotting 
with Myc antibody identifies the most effective shRNA (#1), which was used in all 
subsequent experiment.  
(B) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 and FANCI in 
parental HCT116 (WT) and indicated FANCF knockdown mutants complemented stably with 
shRNA-resistant Myc-tagged FANCF.  
(C) Clonogenic survival of wild type (WT), shFANCF stable knockdown cell line, and two 
complemented cell lines (#6 and #9) against mitomycin C. Error bars for clonogenic survival 
are derived from SDs from three independent tests with triplications.  
(D) Reverse transcription/Q-PCR measuring stable FANCF knockdown in the indicated 
mutant cell lines.  
(E) Immunoblotting with Myc antibody testing FANCF knockdown efficiency in the 
indicated stable cell lines transiently transfected with wild type Myc-FANCF. 
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A-G-20 and C-E-F are required for the full function of FA core complex 
To test whether the C-E-F module functions independently for the full extent of 
FANCD2 ubiquitination, FANCF was knocked down in the FANCG-/- mutant by shRNA 
(Fig. 4.3D-E). As shown (Fig. 4.4A), loss of both FANCF and FANCG completely 
eliminated FANCI/D2 monoubiquitination upon MMC or cisplatin exposure, suggesting that 
FANCG and FANCF provide distinct functions in the FA core complex. The complete loss 
of FANCD2 monoubiquitination resulted from compromised loading/anchoring of FANCL 
at the site of DNA damage, as shown (Fig. 4.4A and B). Consistently, cells deficient of both 
FANCG and FANCF exhibited much more severe sensitivity to MMC than single mutants, 
which is comparable to that of the FANCL mutant (Fig. 4.4C).  
In order to test if FANCF as an initial loading module act independently of the 
anchoring module A-G-20, FANCF chromatin-binding was analyzed in FANCG knockout 
background and found that chromatin-bound FANCF was not affected by FANCG deficiency 
(Fig. 4.4D). Together, these results suggest that the A-G-20 and C-E-F modules can act 
independently to position the catalytic module at the site of DNA damage. 
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Fig. 4.4 A-G-20 and C-E-F modules are required for the full function of FA core complex.  
(A) Immunoblot detecting MMC and cisplatin-induced monoubiquitination of FANCD2 and 
FANCL in wild type (WT) and the indicated knockout/knockdown mutant cells.   
(B) Quantification of chromatin-bound FANCL (left panel of B) in wild type HCT116 (WT) 
and indicated mutants exposed to mitomycin C.  
(C) Clonogenic survival of parental HCT116 (WT), FANCG-/- + Ctrl shRNA, FANCG-/- + 
shFANCF, and FANCL-/- cells treated with mitomycin C.  
(D) Immunoblot detecting chromatin-bound Myc-tagged FANCF in FANCG+/+ and FANCG-
/- cells with stable knockdown of endogenous FANCF and complemented with shRNA-
resistant Myc-tagged FANCF. 
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FANCG and FANCM are required for the full function of FA core complex in 
recruiting FANCL into ICL sites 
The above results suggest that FANCF acts as a loading factor for the FA core 
complex via interacting with FANCM, thus deletion of both FANCM and FANCG is 
expected to completely eliminate the FANCI/D2 ubiquitination by compromising both 
chromatin loading and anchoring machineries of FANCL. To confirm the interaction 
between FANCF and FANCM, immunoprecipitation experiment was performed and we 
found that FANCF indeed binds to FANCM (Fig. 4.5A). Subsequently, we tested FANCD2 
ubiquitination in the FANCG and FANCM knockout mutants. As shown (Fig. 4.5B), only 
loss of both FANCG and FANCM yielded complete loss of FANCD2 monoubiquitination 
compared with the single knockout mutants, further suggesting that the chromatin anchoring 
module and FANCM-dependent loading provide a combined function of placing FANCL to 
the damaged site for ubiquitination action.  
To further verify this notion, FANCL chromatin loading was analyzed in the FANCG 
and FANCM single and double knockout cells. Indeed, either FANCG or FANCM depletion 
results in partial removal of chromatin-bound FANCL, while double depletion completely 
comprised the chromatin recruitment of FANCL (Fig. 4.5B, C). MMC survival assay was 
conducted to test the functional consequence of removing both FANCG and FANCM. The 
results showed that DNA damage sensitivity of the FANCG- FANCM double mutant was 
much more severe than each single mutant (Fig. 4.5D), implying that depleting both loading 
and anchoring factors of the FA catalytic FANCL severely impact the cellular survival.  
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Fig. 4.5 FANCG and FANCM are required for the full function of FA core complex in 
recruiting FANCL into ICL sites.  
(A) Co-immunoprecipitation between FANCF and FANCM. S-tag-Flag-Biotin (SFB) –
tagged FANCF or the empty vector was stably expressed in 293T cells. Protein extracts 
prepared from both cell lines were subjected to streptavidin beads pull down and bound 
proteins were immunoblotted by FANCM or Flag antibodies.  
(B) Immunoblot detecting MMC- and cisplatin-induced monoubiquitination of FANCD2 and 
chromatin loading of FANCL in wild type (WT) and FANCG-/-, FANCM-/-, and FANCG-/- 
FANCM-/- double mutants. 
(C) Quantification of (C) - chromatin-bound FANCL in FANCG-/-, FANCM-/-, and FANCG-/-
M-/- double mutants. Error bars for chromatin fraction represent SDs derived from three 
independent experiments.  
 (D) Clonogenic survival of FANCM-/-, FANCG-/-, FANCL-/-, and FANCG-/- FANCM-/- 
mutants treated with mitomycin C. Error bars for clonogenic survival are derived from DSs 
from four independent tests with triplications. 
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FANCM functions epistatically with the chromatin loading module 
The above results have depicted a model that C-E-F and A-G-20 sub complexes act 
together for the full function of FA core complex in ubiquitination of FANCI/D2 complex. 
As such, it is expected that knockout both FANCM and FANCF would not yield additional 
phenotype than loss of FANCM alone due to the fact that loss of either protein lead to the 
same disruption of the loading module. To test this hypothesis, we analyzed FANCD2 
monoubiquitination in FANCM deficient cells with stable knockdown of FANCF. As shown 
(Fig. 4.6A, B), loss of FANCF in FANCM-/- cells did not generate any additional loss of 
FANCD2 or FANCI monoubiquitination upon ICL damage. Consistently, loss of both 
FANCM and FANCF failed to show further increased sensitivity to mitomycin C than the 
FANCM mutant alone (Fig. 4.6C). Therefore, FANCM and FANCF function epistatically in 
the initial chromatin loading of the FA core complex. 
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Fig. 4.6 FANCM functions epistatically with the chromatin loading module.  
(A) Immunoblot detecting MMC-induced monoubiquitination of FANCD2 and FANCI in 
wild type HCT116 (WT) and the indicated knockout/knockdown mutant cells.   
(B) Immunoblot detecting cisplatin-induced monoubiquitination of FANCD2 in wild type 
HCT116 (WT) and the indicated knockout/knockdown mutant cells.  
(C) Clonogenic survival of HCT116 FANCF knockdown alone (shFANCF), FANCM-/-
+shFANCF, and FANCM-/-+Ctrl shRNA mutants treated with mitomycin C.  
Error bars for clonogenic survival are derived from DSs from four independent tests with 
triplications. 
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Discussion 
Results presented in this chapter define the redundant functions of the A-G-20 sub 
complex and C-E-F sub complex in the damage-specific loading of the FA catalytic core 
activity. The function of A-G-20 as DNA/chromatin anchoring module is independent of 
FANCM mediated chromatin loading mechanism. On the other hand, the C-E-F sub complex 
as a loading module works with FANCM which most likely provides the initial loading of 
the FA core complex. The two modules enable the FA core complex to be positioned to DNA 
damage site, so that FANCL is able to monoubiquitinate FANCD2/I complex in a spatially-
defined fashion. With the capability to recognize stalled forks or processed lesion (Joo et al.) 
and to recruit downstream effectors, including endonucleases (Knipscheer et al., 2009; Kratz 
et al.; Liu et al.; MacKay et al.; Smogorzewska et al.), the ubiquitinated FANCI/D2 therefore 
can tether the upstream DNA damage signaling and the downstream effectors for repair 
purpose. 
Both of the loading and the anchoring modules are important for the full function of 
the FA core complex. With either A-G-20 sub complex or C-E-F sub complex disrupted, the 
phenotype is relatively mild by showing diminished but not fully abolished FANCI/D2 
ubiquitination, and less severe ICL-induced DNA damage killing. Disruption of both, 
however, impedes the essential recruitment of the catalytic FANCL to the damaged site and 
thus fully compromises the monoubiquitination and causes hypersensitivity to ICL reagents. 
This model also explains why the Fancc and Fancg double knockout mice showed more 
severe phenotype than single knockout mice (Pulliam-Leath et al.). In this mouse model 
study, disruption of both Fancc and Fancg led to bone marrow failure, acute myeloid 
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leukemia, and myelodysplasia, which recapitulated the hematologic symptoms of FA 
patients, while the single knockout mice did not. 
A question remains as how A-G-20 sub complex is able to anchor the E3 ligase 
FANCL to the chromatin or DNA damaged site. FANCA has been demonstrated to possess 
DNA binding affinity in vitro (Yuan et al., 2012).  Also FAAP20 has been shown to bind to 
ubiquitinated forms of H2A (Yan et al.), although FAAP20 is likely to play a minor role in 
chromatin association of the E3 ligase which is indicated by the weak phenotypes of 
FAAP20 mutant. Potentially, these DNA/chromatin affinity features of the A-G-20 sub 
complex may contribute to their chromatin anchoring role in FA core complex. Nevertheless, 
further study is needed to fully define biochemical properties of the A-G-20 sub complex 
responsible for damage DNA association.  
FANCM has been shown to constitutively bind to the chromatin and is important for 
the chromatin association of the core complex (Kim et al., 2008). Deletion of FANCM 
results in substantial loss of the chromatin-bound FA core proteins, and moderate defects of 
FANCD2 monoubiquitination (Wang et al., 2013). Thus it is likely that in the absence of 
FANCM-mediated initial loading, the chromatin anchoring module is still able to retain 
certain amount of the E3 ligase at the site of DNA damage, which is sufficient to keep a 
detectable level of FA pathway activation.  
This model explains why FANCG deficient cell line showed more severe phenotype 
than FANCM knockout cells but not a complete loss of FANCD2/I monoubiquitination and 
less severe sensitivity than FANCL. This also explains why only by knocking out both 
FANCG and FANCM, FANCD2 monoubiquitination is completely eliminated and 
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hypersensitivity to ICL agents even surpassed that of the FANCL-/- mutant. The additional 
sensitivity of the FANCG and FANCM double mutant over the FANCL mutant (Fig. 4.5D) is 
most likely attributed to the FA pathway- independent function of FANCM as suggested by 
previous studies (Huang et al.; Wang et al., 2013). 
In summary, our study has delineated the chromatin loading module C-E-F and 
anchoring module A-G-20 for the damage-specific recruitment of the FA core complex E3 
ligase to the ICLs. The epistatic relationships among the FA genes are much more clearly-
defined. This not only accelerates the elucidation of the ICL repair mechanism but also 
enhances the understanding of the disease biology of Fanconi Anemia. 
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CHAPTER V 
Conclusion and Future Directions 
 
Conclusion 
Monoubiquitination of FANCD2 is a central event of the FA pathway activation. 
Studying the mechanism on how the FANCD2 is ubiquitinated is important to dissect the FA 
pathway and DNA repair mechanisms. The goal of our study was to analyze the epistatic 
relationship between FA core genes and elucidate the functions of the FA core components in 
FA pathway activation and DNA interstrand crosslinking damage resistance. Based on the 
modularized FA core complex hypothesis, we tested how the three sub complexes exert 
differential functions contributing to the FANCI/D2 ubiquitination and ICL repair. Our main 
approach is epistatic analysis and functional studies using a panel of isogenic human cellular 
knockout mutants.  
In this study, I found that FA core genes showed variant sensitivity to DNA ICL 
damage. FANCG and FAAP20 null cells were less sensitive than FANCB and FANCL null 
cells to DNA ICLs. Epistatic analyses showed that FANCG and FAAP20 were epistatic to 
FANCB and FANCL, but have less severe phenotypes. This result suggested that B-L-100 
sub complex plays a more important role in ICL repair, although they function in the same 
pathway. Moreover, disruption of genes from the B-L-100 sub complex completely disabled 
the core complex to ubiquitinate the FANCI/D2 complex, while the deficiency of the genes 
from the A-G-20 and C-E-F sub complex only partially reduced the ubiquitination activity. 
Therefore, B-L-100 acts as the E3 catalytic core module in the FA core complex, whereas 
other components play secondary roles. 
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FANCM has been shown to constitutively bind to chromatin and is believed to 
initiate the chromatin loading of the core complex through interacting with FANCF (Deans 
and West, 2009; Kim et al., 2008). By analyzing the chromatin fractions and enrichment of 
the FA core genes at the ICL site in the mutant cells, I found that the A-G-20 acted as a 
chromatin anchoring module for the catalytic core contain FANCL. The removal of either 
FANCG or FANCF resulted in partial reduction of the FANCL chromatin loading and 
FANCI/D2 ubiquitination, while removing both led to additional impact in FANCL 
chromatin loading, abolished FANCI/D2 ubiquitination, and heightened sensitivity to ICL 
reagents comparable to FANCL mutant. In addition, the interaction between FANCM and 
FANCF was also found by my study to support the recruitment of the core complex. ICL 
survival assays, on the other hand, revealed non-redundant functions of the A-G-20 and C-E-
F complexes in ICL repair, most likely reflecting the cooperative nature of core complex 
recruitment. 
Collectively, my studies defined that FA core complex mediate the ubiquitination of 
FANCI/D2 ubiquitination through an assembly of different functional modules, the B-L-100 
catalytic core module, the C-E-F chromatin loading module, and the A-G-20 chromatin 
anchoring module. These findings provided novel mechanistic insights into how FA core 
genes contribute to the FA pathway activation and genomic integrity. 
 
Proposed Model 
Based on our findings, a model is proposed to depict the functional modules of FA 
core complex in its DNA damage-specific recruitment (Fig 5.1). The FA core complex is 
assembled with three functional modules, the catalytic module (B-L-100 sub complex), the 
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chromatin loading module (C-E-F sub complex), and the chromatin anchoring module (A-G-
20 sub complex). FANCM complex constitutively binds to chromatin, when forming a 
complex with FAAP24, exhibit DNA damage binding property (Gari et al., 2008a; Gari et 
al., 2008b; Singh et al., 2010). Upon DNA damage, C-E-F sub complex initiates the transient 
recruitment of FA core complex to the lesion site through interaction between FANCM and 
FANCF, while the A-G-20 complex anchors the FA core complex to the chromatin/lesion 
sites, so that the core complex is stably located at the damaged site to catalyze the FANCI/D2 
ubiquitination reaction. When cells are devoid of either chromatin loading or chromatin 
anchoring module, the FA pathway activation is only partially disabled with intermediate 
hypersensitivity to ICLs. When both chromatin loading and anchoring module are defective, 
the catalytic module fails to be stabilized to the DNA damaged site, leading to complete 
inability of FA pathway activation and high sensitivity to ICLs, which is comparable to 
deficiency of the E3 ligase FANCL. 
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Fig. 5.1 Working model for FA core genes in activating FA pathway.  
FANCM constitutively binds to chromatin and DNA. Upon DNA damage, C-E-F sub 
complex initiates the recruitment of FA core complex to the lesion site through interaction 
with FANCM. After initial loading, A-G-20 anchors the FA core complex to the 
chromatin/lesion sites, where B-L-100 catalyzes the FANCI/D2 ubiquitination reaction. 
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Future Directions 
Chromatin/DNA anchoring machinery of A-G-20 sub complex 
As shown in Chapter IV, A-G-20 sub complex plays a role in anchoring the FA core 
complex at the damaged site. Although a previous study suggested that FANCA had DNA 
binding affinity, no clear DNA- or chromatin-interacting domain was defined (Yuan et al., 
2012).  Thus, it would be important to determine how the A-G-20 sub complex retains the 
core complex. To this end, I am planning to perform a structure-function analysis of 
FANCA. 
By aligning the amino acid sequence of FANCA with known chromatin or DNA 
binding domain, I found that FANCA has a near C-terminal domain which displays similarity 
to the PWWP motif (Fig. 5.2). The PWWP domain is a protein-protein interaction domain 
and some of these domains have been shown to mediate interaction with modified histones. 
For example, the PWWP domain of the MutSα was found to mediate the chromatin binding 
of mismatch repair machinery to the tri-methylated histone H3 (Li et al., 2013). Other 
PWWP domain proteins have been shown to mediate the binding of proteins to the histone 
for the regulation of histone modifications and the downstream DNA damage repair signaling 
(Wang et al., 2009).  
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Fig. 5.2 Sequence alignment of the PWWP domain-containing proteins and FANCA. 
Homozygous mutation sites found in FA patients are indicated by red arrows. The upper 
panel is for the alignment of the core portion of the PWWP domain and the lower panel is for 
the alignment of FFS portion of the PWWP domain. 
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By aligning the sequences of FANCA cross species, I found that this “PWWP-like” 
domain is highly conserved among the homologs, as shown (Fig. 5.3). Furthermore, 
homozygous deletions of the highly conserved core amino acids W1174 or F1263 has been 
found in FANCA complementation group patients, which underscores the importance of the 
two residues in FANCA function (Adachi et al., 2002). In addition, this “PWWP-like” 
domain does not overlap with the N-terminal NLS domain which is responsible for FANCG 
interaction (Garcia-Higuera et al., 2000), or the FAAP20 interacting motif of FANCA which 
includes residues 674-1032 (Leung et al.).  
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Fig. 5.3 Sequence alignment of the “PWWP-like” domain of FANCA homologs across 
species.  
Homozygous single amino acid deletions in FA patients are indicated by red rectangles. 
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The alignment results suggest the existence of a functional “PWWP-like” domain in 
FANCA. Thus we hypothesize that the PWWP domain of FANCA plays a role of anchoring 
the FA core complex to damaged marked histone. To test this hypothesis, the following 
specific aims are planned. 
Specific Aim 1, To determine whether the FANCA PWWP domain is important for 
the chromatin anchoring of the FA core complex upon DNA damage.  
For this purpose, FANCA null cell line will be established with Cas9 targeting 
technology. FANCA PWWP domain mutants will be introduced into a FANCA null cell line 
for chromatin fractionation and eChIP analyses of the FA core proteins. In addition, 
FANCD2 ubiquitination will be examined with chromatin fractionation and cellular 
resistance to ICLs will be assayed with clonogenic assay under ICL treatment. The positive 
control will be wild type FANCA complemented cell line and the negative control will be the 
FANCA null cell line with empty vector introduced.  
It is expected that the chromatin-bound and the lesion-enriched FANCL is 
significantly reduced in the PWWP domain mutants of FANCA compared with the wild type 
FANCA group. The mutants are expected to exhibit less FANCD2 ubiquitination and higher 
sensitivity to ICLs than positive control cell.  If the reduction level is comparable to the 
negative control, the mutated region or residue is essential to the function of FANCA. 
However, if the phenotype is milder than the negative control, the mutated region or residue 
is important but not crucial for FANCA function. Under this scenario, combined mutation 
such as multiple residue mutation or truncation can be generated to study the essential 
domains required for the full function of FANCA. 
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Specific Aim 2, To investigate the histone target of the FANCA PWWP domain upon 
DNA damage.  
For this purpose, the recombinant peptide of FANCA PWWP domain will be 
produced and purified for modified histone peptide array to screen for positive histone 
binding target (Paul et al., 2013; Rothbart et al., 2012). The interaction between FANCA 
PWWP domain and the potential modified histone target will be verified both in vitro by pull 
down assay and in vivo by immunoprecipitation. Furthermore, PWWP domain mutants of 
FANCA will be investigated for their binding ability to the histone target in vitro with the 
recombinant peptides and in vivo with the cell lines generated in specific aim 1. 
If the FANCA PWWP domain possesses modified histone binding affinity, such as 
H3K36me3, the wild type PWWP domain should bind to the target in the array blotting while 
the mutants are deficient. The histone target is expected to be pulled down by the wild type 
PWWP domain peptide but not the mutants. Immunoprecipitation analysis is expected to 
show that, the endogenous FANCA interacts with histone target in the wild type cell line, 
while the mutants have impaired affinity. If the modified histone peptide array fails to work 
due to sensitivity or specificity issue, recombinant FANCA PWWP domain can be 
conjugated onto column to capture and enrich the target peptide from a library of modified 
histones.  
Specific Aim 3, To establish the co-crystal structure of FANCA PWWP domain and 
the target histone.  
For this purpose, collaboration will be needed. This study is expected to gain 
structural validation into how FANCA PWWP domain interacts with the target histone. It 
also explains why certain residues are important for the interaction.  
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 Epistatic analysis of FA genes  
Most of the FA genes involved in FANCD2/I monoubiquitination exist only in 
vertebrate, which makes it difficult to conduct epistatic analysis, since common genetic 
platforms such as yeast and drosophila cannot be used. On the other hand, the delineation of 
the epistatic correlations between the FA genes is important to genetically define the FA 
pathway. As shown in Chapter II-IV, FANCG-/-, FANCB-, FANCG-/-FANCB-, FAAP20-/-
FANCB-, and FANCG-/-FANCM-/-  cell lines were constructed through rAAV-based 
recombination targeting for ICL repair functional analysis. With the same technology, I also 
made FANCM-/-FANCB-, FANCI-/-FANCB- cell lines as shown (Fig. 5.4). To make more 
single and double knockout cell lines to systematically analyze the epistatic relationships 
between FA genes, it would be more efficient to use the newly established Cas9 knockout 
technology, since the rAAV-based recombination targeting is a lengthy and laborious 
procedure. With the generated isogenic mutant cell lines, the function of each gene can be 
further dissected through characterizing these mutant cell lines and performing DNA damage 
functional assays.    
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Fig. 5.4 Construction of human cellular knockout mutants.  
(A) PCR genotyping of the FANCM-/-B- double knockout mutant.   
(B) PCR genotyping of the FANCI-/-FANCB- double knockout mutant.  
(C) Immunoblot detects the indicated FA core protein in whole cell extracts of wild type 
(WT) and indicated mutants.  
Δ, knockout allele. wt, wild type allele. MW, molecular weight size marker. 
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With the current single and double knockout cell lines (FANCG-/-, FANCB-, FANCM-
/-, FANCI-/-, FANCG-/-FANCB-, FAAP20-/-FANCB-, FANCG-/-FANCM-/-, FANCM-/-FANCB-, 
and FANCI-/-FANCB-), clonogenicity was tested for their ability of proliferation and survival. 
As shown (Fig. 5.5), all FA single mutants showed reduced clonogenic ability compared with 
wild-type HCT116 cells. FANCM-/-FANCB- and FANCG-/-FANCM-/- showed further decrease 
of clonogenic ability compared with single mutants. FANCG-/-FANCB- cell and FANCI-/-
FANCB- cell didn’t show additionally reduced clonogenic ability compared with single 
mutants. In all, FA genes play a role in cell survival and/or proliferation. These observations 
also indicate that FANCB, FANCG and FANCI functionally overlap for cell survival and/or 
proliferation, while FANCM has extra function that is not overlapping with the core complex 
gene FANCB or FANCG. 
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Fig. 5.5 Clonogenicity of the FA mutants.  
(A) Plating efficiency of wild type (WT) and FANCI-/-, FANCG-/-, FANCM-/-, and FANCB- 
mutants.  
(B) Plating efficiency of wild type (WT) and FANCM-/-, FANCB-, and FANCM-/-FANCB- 
mutants.  
(C) Plating efficiency of wild type (WT) and FANCG-/-, FANCM-/-, and FANCG-/-FANCM-/- 
mutants.  
(D) Plating efficiency of wild type (WT) and FANCG-/-, FANCB-, and FANCG-/-FANCB- 
mutants.  
(E) Plating efficiency of wild type (WT) and FANCI-/-, FANCB-, and FANCI-/-FANCB- 
mutants.  
Error bars represent SDs derived from three independent experiments. One-way ANOVA 
analysis and Bonferroni multiple comparison tests was used for statistical analysis. *, p<0.05; 
**, p<0.01; ***, p<0.001; ns, not statistically significant. 
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As for cell cycle progression, upon MMC treatment, all FA mutants showed G2/M 
arrest (Fig. 5.6). FANCG-/-FANCM-/- showed highly-increased population in G0/G1 phase 
compared with single mutants and FANCM-/-FANCB- showed mildly-increased population in 
G0/G1 phase, while FANCG-/-FANCB- and FANCI-/-FANCB- didn’t showed more population 
in G0/G1 phase compared with single mutants. All these are consistent with the cell 
clonogenicity results that FANCB, FANCG and FANCI overlap functionally for cell cycle 
progression in response to replication stress, while FANCM has extra functions. 
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Fig. 5.6 Cell cycle profiles of the FA mutants with or without mitomycin C treatment. 
To analyze the cell cycle progression profile, cells were treated with or without MMC for 16 
hours and pelleted after trypsinization and neutralization. The cell pellets were then 
suspended in PBS buffer and fixed with ethanol. The fixed cells were then suspended in 
propidium iodide (PI) staining buffer (5 µg/ml PI in PBS plus 0.2 mg/ml RNase A) in the 
dark for 30 min at room temperature. Then samples were transferred into FACS tubes and 
cell cycle was analyzed by flow cytometry. I, FANCI-/-; G, FANCG-/-; M, FANCM-/-; B, 
FANCB-; GB, FANCG-/- B-; MB, FANCM-/- B-; GM, FANCG-/- M-/-; IB, FANCG-/-M-. 
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In order to study the epistatic relationship between FA genes especially in response to 
ICL-induced DNA damage, MMC survival assay was carried on these mutants (Fig. 5.7). In 
general, single knockout cells were hyper-sensitive to MMC. FANCI-/- and FANCB- showed 
the highest sensitivity followed by FANCG-/-, FANCM-/- showed the mildest sensitivity to 
MMC. Double knockout cell lines, FANCM-/-FANCB-, showed increased sensitivity to MMC 
compared with single mutants, indicating that FANCM and core components only have 
partially overlapping function. On the other hand, FANCB knockout on top of FANCI-/- cells 
didn’t show additional increased sensitivity to MMC, suggesting that FA core component 
genes and I/D2 complex genes are epistatic in ICL resistance. Other DNA damage treatment 
will be applied for a more comprehensive understanding of the function of the FA genes in 
response to various DNA damage stress. 
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Fig. 5.7 Cellular resistance of the FA mutants to mitomycin C.  
(A) Clonogenic survival curves of wild type (WT) and FANCI-/-, FANCG-/-, FANCM-/-, and 
FANCB- mutants under MMC treatment.  
(B) Clonogenic survival curves of wild type (WT) and FANCM-/-, FANCB-, and FANCM-/-
FANCB- mutants in MMC treatment.  
(C) Clonogenic survival curves of wild type (WT) and FANCI-/-, FANCB-, and FANCI-/-
FANCB- mutants. Error bars for clonogenic survival are derived from DSs from four 
independent tests with triplications.  
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To investigate the FA function on genomic stability, cytogenetic analysis was 
performed. FA genes were shown to be important for maintaining genomic integrity upon 
MMC treatment (Fig. 5.8). The abnormal chromosome were counted, the results was 
consistent with MMC survivals, in that FANCG-/-FANCM-/- and FANCM-/-FANCB- showed 
the highest degree of genomic instability, followed by FANCI-/-FANCB- (and FANCB-, 
FANCI-/-), FANCG-/-, and FANCM-/- cell lines. Radial chromosomes were also counted, 
showing significantly increased counts in the FA deficient cells than wild type cells, but there 
was no statistically significant difference among the FA mutant cells. This result suggests 
that radial chromosome counts, as a common phenotype of FA cells, is not able to 
differentiate the importance of the different FA genes in ICL resistance.  
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Fig. 5.8 Cytogenetic characterization of the FA mutants with or without mitomycin C 
treatment.  
(A) Radial chromosomal counts of wild type and indicated mutants treated with mitomycin 
C. Error bars are derived from DSs from two independent tests with triplications.  
(B) Chromosomal aberration counts in wild type and indicated mutants treated with or 
without mitomycin C. Error bars are derived from DSs from more than 50 counts per cell 
line. 
I, FANCI-/-; G, FANCG-/-; M, FANCM-/-; B, FANCB-; GB, FANCG-/- B-; MB, FANCM-/- B-; 
GM, FANCG-/- M-/-; IB, FANCG-/-M-. 
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To further analyze these cell lines in response to ICL, G0/G1 phase ICL repair was 
examined on these mutants. As shown (Fig. 5.9), FANCI-/-, FANCM-/- had impaired 
replication independent ICL repair, while FANCG-/- had increased repair. FANCM knockout 
on top of FANCG-/- negatively affected the recombination-independent ICL repair, which 
indicated that FANCM counteracted with FANCG in G0/G1 phase ICL repair. This could be 
the reason why FANCG and FANCM show severe phenotype in MMC survival assay. It is 
interesting that FANCB knockout didn’t affect this repair, neither did FANCB knockout on 
top of FANCG-/-, FANCI-/- or FANCM-/- affect the G0/G1 phase ICL repair significantly. 
Further mutagenesis assay will be performed to analyze the results of this affected ICL repair 
efficiency which may provide insight into how FA genes functions in this G0/G1 phase 
recombination-independent ICL repair and the overall impact of FA gene defects on G0/G1 
phase cells. 
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Fig. 5.9 Recombination-independent repair efficiency of the FA mutants.  
(A) Recombination independent repair activity analysis of wild type (WT) and FANCI-/-, 
FANCG-/-, FANCM-/-, and FANCB- mutants. 
(B) Recombination independent repair activity analysis of wild type (WT) and FANCM-/-, 
FANCB-, and FANCM-/-FANCB- mutants.  
(C) Recombination independent repair activity analysis of wild type (WT) and FANCG-/-, 
FANCM-/-, and FANCG-/-FANCM-/- mutants.  
(D) Recombination independent repair activity analysis of wild type (WT) and FANCG-/-, 
FANCB-, and FANCG-/-FANCB- mutants.  
(E) Recombination independent repair activity analysis of wild type (WT) and FANCI-/-, 
FANCB-, and FANCI-/-FANCB- mutants.  
XL, stands for interstrand crosslink. Error bars represent SDs derived from three independent 
experiments. The luciferase reporter reactivation assay was performed according to 
previously described protocol to test the recombination-independent ICL repair efficiency 
(Shen et al., 2009).  Briefly, an ICL reporter substrate which blocks transcription of 
luciferase or an undamaged reporter substrate as control (1ng/each) was transfected into each 
cell line together with β-galactosidase plasmid as internal control (50ng). Luciferase assay 
was conducted as standard procedures. The luciferase activity was normalized against the β-
galactosidase activity. The relative luciferase activity of the crosslinked reporter to that of the 
undamaged reporter was calculated as the recombination-independent ICL repair efficiency. 
One-way ANOVA analysis and Bonferroni multiple comparison tests was used for statistical 
analysis. **, p<0.01; ns, not statistically significant. 
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In conclusion, a series of single and double FA gene knockout cell lines were 
established. The characterization of the cell lines and DNA repair related functional assay 
were initiated in these cell lines. In the future, more knockout cell lines will be established to 
undergo functional assays. Therefore, a more systematic genetic relationship network of the 
FA genes will be depicted, and functions of each FA genes will be further clarified. 
 
Role of FA genes in DNA-protein crosslink (DPC) repair 
Hypersensitivity to DNA interstrand crosslinking agents with increased genomic 
instability is the standard diagnostic indicator of FA patient and a cellular hallmark for FA 
pathway deficiency. However, it is still not clear about the nature and the source of 
endogenous crosslinking lesion. In addition to DNA interstrand crosslinks, recent studies 
showed a likely role of the FA pathway in repairing DNA-protein crosslinking (DPC) lesions 
arisen from intrinsic metabolites, acetaldehyde, and formaldehyde (Langevin et al.; Rosado et 
al.). Interestingly, DPC can also induced by ionizing radiation with a relatively high 
frequency (>150/cell/Gy) (Frankenberg-Schwager, 1990). Thus FA genes may play a 
substantial role in countering the replication-blocking damage of DNA-protein crosslinks 
resulting from ionizing radiation during radiation therapy. 
In recent mouse genetic studies from the Patel laboratory, reactive aldehydes have 
been suggested to constitute a key source of the endogenous crosslinking damage (Langevin 
et al.). The Fand2 knockout leads to lethality when combining with the knockout of Aldh5, a 
formaldehyde dehydrogenase gene, which encodes the primary detoxifying enzyme for 
reactive formaldehyde in cells (Rosado et al.). This may also provide a mechanistic 
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explanation for the progressive hematopoietic stem cells depletion manifested in FA patient 
(Boulad et al., 2000; Garaycoechea et al., 2012).  
Besides ethanol and food preservative consumption, another source of endogenous 
aldehyde is histone demethylation, which occurs when cells undergo epigenetic changes. The 
elevated levels of formaldehyde resulting from extensive histone demethylation will 
immediately spread to the DNA and proteins. Since formaldehyde is also an effective DNA-
protein crosslinking agents, the DPCs could be a major kind of endogenous lesion caused by 
formaldehyde. This reaction is extremely possible where proteins such as histones and 
transcription factors are in close contact with chromosomal DNA. Although DPCs have been 
known for a long time, how cells deal with them is poorly understood. In this study, we will 
explore DPC repair mechanism and possible roles of the FA pathway in this repair. 
To analyze the DPC repair mechanism, an in vivo system based on our previous ICL-
repair system (Shen et al., 2006) is being constructed in our lab, and will be used in this 
study. To precisely assess the functions of each FA gene group, a panel of isogenic null 
single and double mutants will be created by homologous replacement targeting mediated 
targeting in somatic cells. Although patient mutants are available, most of them carry 
mutations such as hypomorphic alleles making it complicated to explain the phenotypes. 
Also the individuality makes it very difficult to quantitatively compare cellular phenotypes of 
the patient cells and the non-patient cells. The somatic cellular knockout models, however, 
have the advantage over the patient cells, in that the somatic knockout is isogenic. This strict 
isogenicity allows more accurate functional definition of each gene. Compared with the 
recent short homology-based gene editing technology such as TALEN and the CAS9 
systems, the rAAV-based knockout platform also have the advantage in minimizing off-
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target events which ensures a more unambiguous conclusion (Fu et al., 2013). With the DPC 
repair assay and the isogenic cellular models, investigation will be carried out to fulfill the 
following specific aims. 
Specific Aim 1: To study the role of FA genes in the in vivo repair of DPCs with the 
FA gene deficient cells.  
For this purpose, luciferase expression plasmid containing site-specific DPC lesion, 
which blocks the transcription of the firefly luciferase gene, will be constructed and 
validated. The DPC lesion containing plasmid together with the internal control β-
galactosidase will be transfected into various FA null cells and wild type control cells. 
Luciferase and β-galactosidase dual reporter assay will be performed. The DPC lesion repair 
efficiency will be tested using the relative luciferase activity as readout to determine whether 
cells defective in the FA pathway are particularly vulnerable in response to DPCs.  
It is expected that FA deficient cell lines have significantly decreased DPC lesion 
repair efficiency compared with the wild type control cells, demonstrating that FA genes play 
a role in DPC repair. Different FA mutant cells may show various DPC repair efficiency 
defect. This will suggest FA genes have various roles in DPC repair.  
 Specific Aim 2: To detect the physical recruitment of FA proteins to the DPC site.  
To do this, eChIP plasmid containing site-specific DPC lesion will be generated to 
study the recruitment of FA proteins to the lesion site. This eChIP assay will be performed in 
HEK293 and HEK293-EBNA1cell lines. Since the eChIP plasmid contains an Epstein-Barr 
virus replication origin (EBV-OriP), the HEK293-EBNA1 cell lines with stably expressed 
Epstein-Barr nuclear antigen 1 (EBNA-1) will allow the EBNA-1/ori-P based unidirectional 
replication, while the HEK293 does not (Shen et al., 2006). Therefore, replication-
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independent and replication-dependent recruitments of FA genes to the DPC site are 
measurable. 
Result from the eChIP assay is expected to show significant enrichment of FA 
proteins to the damaged site if the function of the FA pathway is directly involved in DPC 
removal. The enrichment fold of the FA proteins to DPC site may be higher in HEK293-
EBNA1 cell than HEK293 cell. This indicates the presence of replication-dependent 
recruitment mechanism of FA proteins. 
Specific Aim 3: To test the epistatic relationship between FA pathway and the 
formaldehyde detoxifying pathway when encountering DPCs in human cell line.  
Although previous mouse study has already shown that the Fand2 and Aldh5 double 
knockout leads to lethality (Rosado et al.), studies of epistatic relationship between FA 
pathway and the formaldehyde detoxifying pathway are still needed. The reason lies in the 
probability of different etiology between human and mouse due to the facts that FA knockout 
mice was not able to recapitulate the phenotype of the FA patients (Koomen et al., 2002; 
Yang et al., 2001). To this end, FA-ALDH5 double knockout cells will be generated through 
Cas9 target strategy. Clonogenic assay will be performed and chromosomal aberration will 
be counted with the single and double knockout cell lines and the wild type control cell line 
under the treatment of formaldehyde or other acetaldehyde. This study can also be extended 
to test the genetic interaction of FA genes with ALDH5 in response to other genotoxins. 
It is expected that defects in both cellular protection pathways will lead to 
substantially increased chromosomal abnormality and impaired cell survival. The cell lines 
defective in either FA pathway or ALDH5 detoxify pathway may not show severe phenotype 
to aldehyde comparable to the double deficient cell line, which indicates redundant functions 
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between the two pathways in response to DPCs. All these results will lead to the conclusion 
that DPCs is an important endogenous lesion endangering genomic integrity and cell survival 
of humans.  
 
In summary, my thesis study and future studies provide novel mechanistic insights 
into how FA genes coordinately contribute to resist against crosslinking damage and mediate 
the spatially defined monoubiquitination of FANCI/D2 complex. It also shed light on the 
disease biological features in different subtypes. These findings can help to identify the 
disease characteristics of different subtypes and develop personalized and more effective 
therapy for FA patients.  
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